The present disclosure generally relates to the field of bionic interphases. More specifically, the disclosure relates to machine control of physiological functions by way of controlled stimulation (e.g. electrical stimulation). The disclosure has example applications for treating hypotension (low blood pressure) in subjects affected by spinal cord injury.
Spinal cord injury (SCI) results in disconnection of some, most, or all descending sympathetic pathways that carry signals responsible for regulating blood pressure. When arterial blood pressure drops or increases following SCI, the spinal cord neurons responsible for blood pressure control no longer have the capacity to maintain blood pressure at a normal physiological level. This disconnection of sympathetic pathways can lead to a situation where blood vessels do not maintain appropriate tone (e.g. the blood vessels can become dilated). As a result, subjects affected by SCI can suffer from extreme hypotension (very low blood pressure). Large amounts of blood may pool in subjects' legs and gut.
Individuals with SCI are often unable to regulate their blood pressure and typically experience a very low arterial blood pressure at rest, during exercise and/or when assuming a seated or standing position. This hypotension can lead to dizziness, disorientation, reduction in cognitive functioning, loss of consciousness and a predisposition to strokes and heart attacks. On the other hand, dangerous elevations in blood pressure (hypertension) can also result from SCI. Hypertension can lead to heart attacks, strokes, and sub-clinical vascular consequences.
Despite widespread misconceptions, autonomic and cardiovascular dysfunctions following SCI are a top health priority (above walking again) and are a main cause of death for individuals with SCI. One primary autonomic issue after high-level SCI (i.e., above the 6th thoracic segment) is orthostatic hypotension, which is clinically-defined as a ≥20 mmHg decrease in systolic blood pressure and/or a 10 mmHg decrease in diastolic blood pressure when assuming the upright posture.
Another critical autonomic issue after SCI is autonomic dysreflexia, which is associated with potentially life threatening elevations in blood pressure due to afferent input activating sympathetic circuitry located caudally on the spinal cord to the location of the SCI. Clinically, autonomic dysreflexia is defined as elevations in systolic blood pressure of 20 mmHg or more.
Currently, the main options for managing blood pressure lability after SCI are pharmacological agents that either can increase or decrease blood pressure. However, most pharmacological tools available for managing orthostatic hypotension and autonomic dysreflexia have significant side effects, as well as a delayed onset of action (at least 10 minutes for drugs to manage high blood pressure, and 60 minutes or more for drugs that manage low blood pressure), and therefore are sub-optimal for managing transient (seconds), but drastic, changes in blood pressure that occur after SCI and other neurological conditions such as multiple sclerosis, autonomic failure, autonomic neuropathy, as well as cancer of the neurological tissue. Importantly, the effects of some of the antihypertensive drugs (e.g. for management of autonomic dysreflexia) can result in a significant decrease in arterial blood pressure, below the desired level, which can last for hours and requires monitoring and further management. As such, pharmacological intervention is often ineffective and can predispose an individual with SCI to extreme changes in blood pressure. Alternative options for controlling blood pressure without the adverse effects inherent to current pharmacological therapies are therefore needed.
The following references provide background to the technology described in the present application:
Patent literature in the general field of the present technology includes:
US20110202107A1 2011 Aug. 18 BLOOD PRESSURE STABILIZATION SYSTEM USING TRANSDERMAL STIMULATION describes electric stimulation apparatus for treating hypotension of patients with spinal cord injury and a method for treating hypotension. The apparatus comprises: a blood pressure measuring means for continuously measuring a blood pressure of a subject; an electric current application means for intermittently applying an electric current to skin of the subject; and a control means for controlling the electric current application means so as to maintain the blood pressure at a predetermined target blood pressure value by activating the electric current application means when the subject blood pressure is equal to or less than the target blood pressure value.
JP2004065529A 2004 Mar. 4 BLOOD PRESSURE CONTROLLING APPARATUS describes a blood pressure controlling apparatus which controls a blood pressure in place of a blood pressure control center of the brain without relying on administration of a hypertensor into a vein or blood transfusion. The apparatus has a blood pressure sensor for detecting a blood pressure value of a living body and an electric stimulation part outputting stimulative electricity to be given to the spinal sympathetic nervous system of the living body. A stimulation frequency control part which calculates the stimulation frequency of a stimulative electricity that needs to be given to the spinal sympathetic nervous system of the living body for raising the blood pressure value of the living body to a target set value. A pulse current output part which outputs the stimulative electricity of the stimulation frequency calculated by the control part.
US20130237948A1 2013 Sep. 12 DEVICES FOR REGULATION OF BLOOD PRESSURE AND HEART RATE describe devices for regulation of blood pressure and heart rate which involve applying electrical treatment signals selected to at least partially block nerve impulses, or in some embodiments, to augment nerve impulses. The apparatus provides a therapy program to provide a downregulating signal to one or more nerves including renal artery, renal nerve, vagus nerve, celiac plexus, splanchnic nerve, cardiac sympathetic nerves, and spinal nerves originating between T10 to L5. In embodiments, the apparatus provides a therapy program to provide an upregulating signal to one or more nerves including a glossopharyngeal nerve and/or a tissue containing baroreceptors.
US20130289650A1 2013 Oct. 31 Neuromodulation for Hypertension Control describes use of neuromodulation for controlling hypertension and other cardiorenal disorders of a patient. A neuromodulation device is configured to be delivered to a patient's body and to apply an electric activation to decrease renal sympathetic hyperactivity of the patient based on monitored blood pressure of the patient, substantially without thermal energization of the patient's body by applying the electric activation. The electric activation may also depend on monitored blood volume of the patient. A feedback control module may be used to provide feedback control information for adjusting the electric activation based on the monitored blood pressure and volume of the patient.
WO2017146659A1 2017 Aug. 31 A SYSTEM FOR DECREASING THE BLOOD PRESSURE describes a blood pressure decreasing system that decreases blood pressure of a patient by non-invasively blocking the sympathetic innervation of the kidney;
US20170056661A1 2017 Mar. 2 METHOD OF REDUCING RENAL HYPERTENSION AND COMPUTER-READABLE MEDIUM describes a method of reducing renal hypertension by applying stimulation to a target zone of an organism using an electronic stimulation device.
US20170007320A1 2017 Jan. 12 RENAL NEUROMODULATION FOR TREATMENT OF PATIENTS and U.S. Pat. No. 9,314,630 B2 2016 Apr. 19 describes a method and apparatus for treatment of heart failure, hypertension and renal failure by stimulating the renal nerve.
U.S. Pat. No. 8,740,825 B2 2014 Jun. 3 Methods and devices for treating hypertension describes devices, systems and methods which control blood pressure and nervous system activity by stimulating baroreceptors and/or nerves to reduce blood pressure.
US20130296965A1 2013 Nov. 7 METHOD FOR BLOOD PRESSURE MODULATION USING ELECTRICAL STIMULATION OF THE CORONARY BARORECEPTORS describes apparatus comprising a first stimulation circuit and a control circuit. The stimulation circuit is configured to be electrically coupled to a first electrode assembly that is configured to deliver electrical sub-myocardial activation stimulation to a coronary baroreceptor from a location within a left atrial appendage of a heart.
There remains a need for apparatus and methods that can help people who are suffering from dysregulated autonomic functions as a result of SCI.
The present disclosure describes technology that has a number of aspects. These aspects may be applied in combination with one another but may also have individual application. These aspects include, without limitation:
A device and algorithm for controlling an autonomic process in a subject using electrical stimulation. The device and algorithm of the present disclosure are based on the surprising discovery that the electrical excitation of spinal cord circuitry caudal to SCI can control the activity of disconnected sympathetic circuitry to regulate blood pressure.
A method performed by a device for generating control signals for a stimulation device.
Methods for regulating blood pressure in subjects affected by SCI. The methods may be effective to alleviate hypotension in such subjects.
Methods for controlling stimulation delivery devices to generate stimulation that may be effective for controlling one or more autonomic functions in a subject.
A system and methods for controlling one or more autonomic functions in a subject.
A method for medical treatment of a subject affected by SCI.
A device according to an example embodiment comprises a processing unit and circuitry that may be configured such that the device may act as an interface between 1) a physiological monitor (e.g., a blood pressure monitor), and 2) a stimulation device (e.g. an electrical stimulation assembly). The device may interface with a variety of physiological monitors and stimulation devices. The device may optionally be connected wirelessly to either or both of the physiological monitor and the stimulation device.
The device may be configured to receive and analyze information from the physiological monitor. The device may be configured to direct an electrical stimulation assembly to transmit output electrical stimulation (or another type of stimulation device to generate other stimulation). The output electrical stimulation may be epidural, for example. The device may cause the stimulation output to increase or decrease depending on the information received from the physiological monitor. The stimulation output may remain constant depending on the information received from the physiological monitor. The stimulation output may improve control of an autonomic function such as blood pressure. The device may operate by feedback control.
The device may be for use in a subject having dysregulated blood pressure. The dysregulated blood pressure may be due to SCI or other neurological conditions such as multiple sclerosis, autonomic failure, autonomic neuropathy, as well as cancer of the neurological tissue. The output electrical stimulation may raise or lower blood pressure in a subject with dysregulated blood pressure according to a set of predetermined parameters. The output electrical stimulation may be useful for controlling hypotension in a subject affected by dysregulated blood pressure.
Another aspect of the disclosure provides apparatus for controlling blood pressure in a subject. The apparatus comprises an input for receiving a BP signal indicative of a blood pressure measurement and a feedback control circuit connected to receive the BP signal from the input and to deliver a stimulation control signal to an output. The feedback control circuit is configured to: compare the blood pressure measurement to a target blood pressure range, if the comparison indicates that the blood pressure measurement is below the target blood pressure range increase a level of the stimulation control signal until the blood pressure measurement is in the target blood pressure range; and if the comparison indicates that the blood pressure measurement is above the target blood pressure range decrease a level of the stimulation control signal until the blood pressure measurement is in the target blood pressure range.
Another aspect of the disclosure provides a method for operating apparatus to control a subject's blood pressure. The method comprises: receiving at the apparatus a signal containing a blood pressure measurement indicative of the subject's blood pressure and comparing the blood pressure measurement to a predetermined target range stored in a data store accessible to the apparatus If the comparison indicates that the blood pressure measurement is below the target blood pressure range the method increases a level of a stimulation control signal until the blood pressure measurement is in the target blood pressure range. If the comparison indicates that the blood pressure measurement is above the target blood pressure range the method decreases the level of the stimulation control signal until the blood pressure measurement is in the target blood pressure range.
Another aspect of the disclosure provides apparatus for controlling one or more autonomous functions in a subject. The apparatus comprises: an input for receiving a monitor signal indicative of a parameter value and a feedback control circuit connected to receive the monitor signal from the input and to deliver a stimulation control signal to an output. The feedback control circuit is configured to: compare the parameter value to a target range. If the comparison indicates that the parameter value is below the target range the control circuit increases a level of the stimulation control signal until the parameter value is in the target range; and if the comparison indicates that the parameter value is above the target range the control circuit decreases a level of the stimulation control signal until the parameter value is in the target range.
Another aspect of the disclosure provides a method for operating apparatus to control one or more autonomous functions of a subject. The method comprises: receiving at the apparatus a signal containing a monitor measurement indicative of a parameter value; comparing the parameter value to a predetermined target range stored in a data store accessible to the apparatus; and, if the comparison indicates that the parameter value is below the target range increasing a level of a stimulation control signal until the parameter value is in the target parameter value range; and if the comparison indicates that the parameter value is above the target range decreasing the level of the stimulation control signal until the parameter value is in the target range.
Another aspect of the disclosure provides the use of any apparatus as described herein for controlling an autonomic function of a person affected by SCI.
Another aspect of the disclosure provides a method for medical treatment of subjects who have dysfunctional regulation of blood pressure or another autonomic function as a result of SCI (broadly interpreted as any condition which impairs operation of descending sympathetic pathways that normally facilitate control of autonomic functions). The method involves regulating the autonomic function by applying stimulation to structures in the lower back caudal to the SCI. The stimulation may comprise stimulating dorsal roots, dorsal afferent fibres and/or intraspinal structures that are connected directly or indirectly to sympathetic preganglionic neurons that affect the function being controlled.
The stimulation may be provided, for example, in the form of electrical stimulation. The electrical stimulation may be delivered to the dorsal aspect of the spinal cord of the subject, for example by way of an implanted electrode structure. The electrode structure is located caudal to the SCI, for example over the lumbosacral spinal cord segments (e.g. at T11-L1 vertebral levels). The method may involve feedback control of the stimulation based on monitoring a parameter that represents activity of the function being regulated. For example, the function may be blood pressure regulation and the parameter may be a blood pressure measured by a blood pressure monitor.
Further aspects of the disclosure and features and combinations of features of example embodiments are illustrated in the accompanying drawings and described below.
The accompanying drawings illustrate non-limiting examples of the present technology.
Throughout the following description, specific details are given as examples in an attempt to impart a thorough understanding of the disclosure. However, the disclosure may be practiced in various forms not all of which embody such details. In other instances, well known elements have not been shown or described in detail to avoid unnecessarily obscuring the disclosure. Accordingly, the specification and drawings are to be regarded in an illustrative, rather than a restrictive sense.
One aspect of the present technology provides devices for automated control of a dysregulated autonomic function (such as blood pressure, bladder control and bowel control) in subjects. Such devices have particular application in treating subjects affected by SCI or other neurological conditions such as multiple sclerosis, autonomic failure, autonomic neuropathy, or cancer of the neurological tissue which impair operation of descending sympathetic pathways that normally facilitate control of autonomic functions.
Control circuit 14 is configured to receive and analyze information from monitor 12. In the
The stimulation may be in any of one or more different forms. For example, the stimulation delivered by stimulation device 16 may comprise one or more of:
In some cases the stimulation is delivered to the dorsal aspect of the spinal cord of a subject. The stimulation may affect dorsal roots, dorsal afferent fibres and/or intraspinal structures that are connected directly or indirectly to sympathetic preganglionic neurons that affect the function being controlled. The stimulation may be delivered caudal to a location of an SCI which has interrupted autonomic control of the function. While the inventors do not intend to be bound by any theory of operation, it is thought that stimulation delivered to affect dorsal roots, dorsal afferent fibres and/or intraspinal structures may be processed by neural structures in the spinal cord, particularly structures caudal to the SCI to cause signals on efferent nerves that, in turn, affect operation of the function being controlled.
Control circuit 14 may be integrated with monitor 12 and/or stimulation device 16 or may be provided as a stand-alone device that acts as an interface between monitor 12 and stimulation device 16. Where control circuit 14 is provided as a part of a stand-alone device, the device may comprise a specialized device or a programmed general purpose device such as a stand-alone CPU, microprocessor, mobile phone, tablet, etc.
The following sections provide more detailed example applications of the present technology to the control of blood pressure in subjects affected by SCI. It should be appreciated that all of these examples may be readily adapted for control of another function by replacement of a blood pressure monitor with a monitor that detects a parameter relevant to the function to be controlled and by suitable choice of stimulation. These examples describe electrical stimulation but may be adapted to use other types of stimulation by suitable choice of an alternative stimulation device.
Control circuit 14′ is configured to receive and analyze information from blood pressure monitor 12′. The information may comprise, for example, a diastolic blood pressure, a systolic blood pressure, or a diastolic blood pressure and a systolic blood pressure. In response to the determination, control circuit 14′ controls a stimulation circuit 16′ to apply signals to the patient by way of electrode(s) 18.
Control circuit 14′ may control any of a wide range of characteristics of electrical signals to be delivered by way of electrodes 18. For example, control circuit 14′ may control one or any combination of: electrical stimulation voltage, the frequency of electrical stimulation, the pulse width of stimulation, the amplitude of stimulation, or any permutation of these factors or other electrical characteristics. The result is that apparatus 10′ delivers electrical stimulation based on information received from the blood pressure monitor.
The signals delivered by control circuit 14 or 14′ may, for example, comprise commands to be executed by a processor or other device in stimulation circuit 16′ and/or parameters to be used by simulation circuit 16′ in generating the stimulation and/or a waveform for stimulation signals in analog or digital form and/or a selection of a program to be used by stimulation circuit 16′ in generating the stimulation.
Control circuit 14 or 14′ may, for example, comprise one or any combination of: a programmed data processor (such as a microprocessor, industrial controller, embedded processor or the like), hardwired logic circuits and/or configurable logic circuits. Control circuit 14 comprises or has access to a data store or data registers which can contain parameters which affect control of the subject's blood pressure.
Embodiments of the disclosure including various designs for control circuit 14 or 14′ may be implemented using any of:
Examples of specifically designed hardware are: logic circuits, application-specific integrated circuits (“ASICs”), large scale integrated circuits (“LSIs”), very large scale integrated circuits (“VLSIs”), and the like. Examples of configurable hardware are: one or more programmable logic devices such as programmable array logic (“PALs”), programmable logic arrays (“PLAs”), and field programmable gate arrays (“FPGAs”)). Examples of programmable data processors are: microprocessors, digital signal processors (“DSPs”), embedded processors, graphics processors, math co-processors, general purpose computers, server computers, cloud computers, mainframe computers, computer workstations, and the like. For example, one or more data processors in a control circuit 14 may implement methods as described herein by executing software instructions in a program memory accessible to the processors.
Processing may be centralized or distributed. Where processing is distributed, information including software and/or data may be kept centrally or distributed. Such information may be exchanged between different functional units by way of a communications network, such as a Local Area Network (LAN), Wide Area Network (WAN), or the Internet, wired or wireless data links, electromagnetic signals, or other data communication channel.
A processing unit
Circuitry which may comprise:
Device 102 may interface with blood pressure monitor 101 and electrical stimulation assembly 103 in any suitable manner including wirelessly. Interfaces 102A and 102C may, for example, comprise:
In some embodiments both of interfaces 102A and 102C are provided by the same physical hardware.
Blood pressure monitor 101 may comprise any blood pressure measuring device. For example, blood pressure monitor 101 may be provided by any of:
Electrical stimulation assembly 103 may be provided by any suitable stimulation assembly capable of providing spinal cord electrical stimulation as described herein. For example, electrical stimulation assembly 103 may comprise a commercially-available electrical stimulation device. The electrical stimulation assembly may, for example, provide epidural spinal cord stimulation.
The electrical stimulation assembly may comprise one or more stimulation electrodes 103B connected to an electrical pulse generator 103A. In some embodiments electrodes 130B are provided on an implantable device. The implantable device may, for example, comprise a commercially available electrode paddle. A wide range of suitable implantable electrode structures are commercially available. These electrode structures differ in the number of electrodes provided (configurations which include 8, 16, or 32 electrodes and associated contact leads are common). Such structures may be designed for surgical or percutaneous application and are dimensioned to fit within the dimensions of the spinal canal at the appropriate spinal segment.
Device 102 may be programmed to decide, based on pre-determined criteria, the appropriate stimulation output to be supplied by electrical stimulation assembly 103. The criteria may, for example, include one or more of:
The appropriate stimulation output may, for example, be based on a predetermined target blood pressure range for an individual. The target blood pressure range may, for example, be predetermined by a medical professional (e.g. a physician, pharmacist, physician-aid or other trained operator). The target blood pressure range may be predetermined based on the resting blood pressure of the subject prior to stimulation, and/or other criteria as determined by a medical professional. In some embodiments the target blood pressure range is adjustable based upon a user input that allows a medical professional and/or the subject to move the target blood pressure range toward higher or lower blood pressures. The user input may be provided for example using programmer 102G or some other interface that is connected to control device 102.
The appropriate stimulation output may also be based on the comfort and/or safety of the subject. For example, the stimulation output may be selected so that a stimulation level is kept lower than a threshold above which the stimulation becomes uncomfortable to the subject and/or causes side effects such as spasticity.
The appropriate stimulation output may optionally be based on a mode of operation of device 102. For example, device 102 may have a plurality of routines where each routine may specify different parameters. For example, a “Morning sit up stimulation routine” may control for a higher blood pressure than an “afternoon resting routine”. In some embodiments a subject may select among the plurality of routines using programmer 102G or some other interface that is connected to control device 102. In some embodiments, device 102 incorporates a scheduler that automatically selects one of a plurality of routines based on time of day.
The appropriate stimulation output may be expressed as characteristics of one or more electrical stimulation signals to be delivered to the subject. These characteristics may, for example, comprise:
Method 200 includes loop 206 which begins by comparing at 208 the current average blood pressure from block 204 to the target range. If the presently measured average blood pressure exceeds the target range then block 210A triggers a reduction of the stimulation level. If the presently measured average blood pressure is within the target range then block 210B holds the stimulation at the current level. If the presently measured average blood pressure is below the target range then block 210C triggers an increase of the stimulation level. Block 212 delays for a short period before the next iteration of loop 206.
An increase or reduction of the stimulation level may be achieved by incrementally increasing or reducing the stimulation level. The increments may be predetermined fixed increments or may be set based on factors such as how far away from the target range is the presently measured blood pressure. In an example embodiment the increment size is increased in proportion to a difference between the presently measured blood pressure and the closest part of the target blood pressure range. Increments for increasing and decreasing the stimulation level may be the same or different. Another way to increase or reduce the stimulation level comprises ramping the stimulation level up or down. The rate(s) at which the stimulation level are ramped up or down may be fixed or variable. In some embodiments the rates of increase and/or decrease are set as a function of a difference between the presently measured blood pressure and the closest part of the target blood pressure range. The rates of increase and/or decrease may be higher when a difference between the presently measured blood pressure and the closest part of the target blood pressure range is larger.
In some embodiments the stimulation voltage is elevated in increments having sizes in the range of 0.1 V-10 V. The stimulation assembly may be configured, for example, to elevate voltage in 0.5 V increments. The voltage may be elevated incrementally. The voltage increments may be predetermined by a medical professional. The voltage increments may be determined on a per subject basis.
The increments may be selected depending on the type of stimulation assembly used. For example, where an epidural stimulation assembly is used, the electrical stimulation may be elevated in increments in the range of about 0.1V to 30 V (or about 0.4V to about 2.5V). As another example, where a transdermal stimulation assembly is used, the electrical stimulation may be increased by delivering higher currents. For example, electrical current may be elevated in increments in the range of about 0.1 to about 150 mA (in some embodiments, the increments of electrical current are about 20 mA).
If blood pressure does not elevate into the target range in response to an incremental increase in stimulation level, then sub-loop 223 may further increase stimulation voltage at the predetermined increment until a blood pressure within the target blood pressure range is reached or until a maximum stimulation level has been reached. As mentioned above, the maximum stimulation level may be set to preserve the subject's comfort and/or safety.
In some embodiments method 200 stops increases in stimulation level in response to receiving a “STOP” command. The stop command may be issued in response to the subject activating a button or other control, for example.
Blood pressure may not respond instantaneously to excitation of sympathetic preganglionic neurons, and therefore there may be a lag between commanding a change in a stimulation level and a consequential change in the subject's blood pressure. For this reason, method 200 provides a lag duration between a time when a stimulation level is set and a next time at which the stimulation level adjustment. This lag may be on the order of seconds, for example. In some embodiments the lag is at least 10 seconds. The device can operate with a variety of lag durations from 1 second to an hour or more on a per subject basis. For example, the device provides a lag duration in the range of a few seconds to 15 minutes. In some embodiments, the device provides a lag duration of about 10 seconds.
In some embodiments the lag is variable. For example, the lag may be reduced in cases where the presently measured blood pressure is far from the target range and the lag may be increased in cases where the presently measured blood pressure is close to or within the target range.
If a blood pressure within the target range is reached (block 220A), the stimulation level may be maintained until blood pressure deviates from the target range.
If blood pressure is above the upper threshold of the predetermined target range (block 220C) then sub-loop 224 is performed to reduce blood pressure by reducing the stimulation level supplied by stimulation system 103. For example, stimulation voltage and/or current may be reduced. In this manner the stimulation level may be reduced until a blood pressure within the target blood pressure range is reached.
The reduction may be incremental. For example, voltage and/or current increments may be predetermined by a medical professional and may be the same as or different from the increment used in sub loop 223. The increments may be determined on a per subject basis. Stimulation voltage may be reduced in increments in the range of 0.1 V-10 V for example. In some embodiments, stimulation assembly 103 reduces voltage in increments of about 0.5 V each time sub-loop 224 is executed. If a blood pressure within the target range is reached (block 220A), the stimulation intensity may be maintained until blood pressure deviates from the target range.
The stimulation increments may vary depending on the type of stimulation assembly used. For example, where a transdermal stimulation assembly is used, the electrical stimulation may be decreased in increments in the range of about 0.1 mA to about 150 mA (or about 20 mA). Where an epidural stimulation assembly is used, the electrical stimulation may be decreased in increments in the range of about 0.1V to about 30V (or about 0.3V to 2.4V, for example 2V, or about 0.5V).
If blood pressure does not decrease sufficiently in response to an incremental decrease in voltage by sub-loop 224, then stimulation voltage may be further decreased by the predetermined increment until a blood pressure within the target blood pressure range is reached.
Blood pressure may not respond instantaneously to the reduction of excitation of sympathetic preganglionic neurons, and therefore there may be a lag of at least 10 seconds between stimulation and the subsequent blood pressure detection and voltage adjustment. The device can operate with a variety of lag durations from 1 second to several hours on a per subject basis. For instance, the device can operate with a lag duration from a few seconds to 15 minutes. In some embodiments, the device operates with a lag duration of less than about 1 minute, such as a lag duration of about 10 seconds.
In some embodiments, the stimulation output has one or any combination of two or more of the following characteristics:
In some embodiments where the stimulation signals are delivered by way of an epidural stimulator the stimulation output has a voltage in the range of about 0.1 V to about 20 V and an amperage in the range of about 0 mA to about 100 mA.
In some embodiments where the stimulation signals are delivered by way of a transcutaneous stimulator the stimulation output has a voltage in the range of about 0.1 V to about 100 V and an amperage in the range of about 0 mA to about 100 mA.
In accordance with one aspect of the disclosure, the device may be used to control blood pressure in a subject with dysregulated blood pressure. The dysregulated blood pressure may be due to SCI or other neurological conditions including, but not limited to, multiple sclerosis, autonomic failure, autonomic neuropathy, as well as cancer of the neurological tissue. The device may be used to control blood pressure in a subject with SCI. In one aspect of the disclosure, the device may control electrical stimulation of the spinal cord. Electrical stimulation of the spinal cord may be performed caudal to injury. Electrical stimulation of the spinal cord may be performed at spinal segments T1-L1, as well as anywhere over the thoracic segment where sympathetic preganglionic neurons are stimulated to elicit a blood pressure effect.
Methods and apparatus as described herein may be applied in combination with pharmacological agents that affect blood pressure. For example, methods and apparatus as described herein may be applied to a subject who is being treated with a pharmacological agent for increasing blood pressure. The use of the present apparatus and methods may reduce the dosage of the pharmacological agent required and/or the time between doses of the pharmacological agent. This may reduce side effects of the pharmacological agent in some cases. Further, use of the present apparatus and methods may maintain control over blood pressure during the time required for a dose of the pharmacological agent to take effect.
The present disclosure may be applied to control autonomic functions other than blood pressure. For example, apparatus and control algorithms as described herein may be applied for controlling a variety of autonomic processes in a subject using electrical or other stimulation. Autonomic processes may include regulation of blood pressure, bladder/bowel control, sexual function, etc.
A device comprising a circuit 14 as described herein may receive input from any of a variety of physiological monitors and control a variety of electrical stimulation assemblies in response to the inputs. Such a device may be configured to receive information from the physiological monitor, and analyze such information based on a control algorithm as described above for example. The device may be configured to direct the electrical stimulation assembly to transmit output electrical stimulation based on the control algorithm. The output electrical stimulation may be transdermal or epidural. In some embodiments, epidural delivery of electrical stimulation is used. The stimulation output may increase or decrease depending on the information received from the physiological monitor. The stimulation output may remain constant depending on the information received from the physiological monitor. The stimulation output may improve control of any of a range of autonomic functions. The control interface may operate by feedback control.
For example, epidural spinal cord stimulation as described may be applied to acutely modulate bladder and/or bowel function in subjects affected by SCI. This may be done by providing a program to deliver stimulation that facilitates urination and/or bowel function and providing an interface that allows a subject to input a command to perform the program. The program may specify a type of stimulation that is specific to bladder/bowel control and that does not significantly affect blood pressure or other functions. A device as described herein may be configured to temporarily suspend active control over BP while performing a bowel/bladder control program and/or the bladder/bowel control program may be performed in parallel with control of blood pressure or other autonomous functions as described herein.
For example, in an example case a program that involved applying electrical stimulation comprising a pulse width 450 ms, a frequency of 45 Hz, and an intensity of 6V for a stimulation time of 105 s led to an increase in external anal sphincter/pelvic floor muscle tone (as measured by EMG) and detrusor pressure (Pdet). This stimulation was found to reduce the time required for bowel evacuation from 117 to 23 minutes (i.e. >80%). The stimulation was applied using a subset of the electrodes provided by an implanted 16-electrode array (Specify 5-6-5, Medtronic, Minneapolis, MN, USA) placed at the T11-L1 vertebral levels and driven by a neurostimulator (RestoreAdvanced SureScan™ MRI neurostimulator). The subset of electrodes was selected to affect bladder/bowel function.
In some embodiments blood pressure monitor 101 is replaced with a monitor for measuring urinary bladder/bowel volume. In such embodiments a measured bladder volume may be processed to alter signals delivered to control bowel/bladder function.
Without committing to any particular theory of operation, it is thought that stimulation delivered by way of such electrodes may activate sympathetic and/or parasympathetic spinal neuronal structures in the lower part of the spinal cord to cause changes of functions in blood vessels, bladder, bowel and/or sexual organs. The neuronal structures involved may be located within the T11 to S5 segments of the spinal cord, for example. Stimulation may be configured to control a particular function by selecting electrodes and/or the nature of the stimulation.
The desired structures may be stimulated transdermally. Transdermal stimulation may incidentally also activate afferent fibres in skin/underlying tissue.
Blood pressure or another function may be controlled by electronic feedback control. This may be done by monitoring one or more parameters that indicate activity of the function being controlled and setting a level of the stimulation based on the monitored parameters. In the case of blood pressure the monitored function may be blood pressure itself (measured using any available blood pressure monitoring modality). The stimulation level may be controlled to keep blood pressure within a target range. Such stimulation may be particularly useful for raising blood pressure to counteract the extreme hypotension that often accompanies SCI.
In some embodiments the method involves administering to the subject pharmacological agents that have the effect of raising blood pressure and adjusting the stimulation level automatically to maintain the desired blood pressure taking into account the effect of the pharmacological agent. This control may cause the stimulation level to be higher in the period before the pharmacological agent takes full effect. The stimulation level may be lower (or off) when the pharmacological agent is fully effective. The stimulation level may then increase as the pharmacological agent is metabolized or excreted or otherwise ceases to maintain blood pressure.
In some embodiments the method may comprise selection of a program for control of an autonomic function. Different programs may be provided for the same autonomic function. Different programs may differ, for example, in one or more of:
A program may be selected from among a plurality of programs in response to user input by way of a suitable control, an automatic scheduler and/or the like. Where the stimulation is delivered by way of apparatus as described herein, programs may be defined by stored data which may be resident in a control circuit (e.g. 102) or a stimulator (e.g. 103) or a device which combines these functions, for example.
In some embodiments, the method may include control of plural autonomic functions. For example, the method may involve controlling blood pressure and also controlling bladder/bowel function. In such cases, different stimulation may be provided for each of the autonomic functions. The stimulation for the different functions may be selected in such a manner that the stimulation associated with one function does not significantly affect another function. This may be achieved, for example, in the case of electrical stimulation, by one or more of:
Control of the bladder/bowel function may be applied selectively to assist a subject with urination and/or bowel voiding. Where this is done in combination with control over blood pressure the stimulation for blood pressure control may be performed concurrently with stimulation of bowel/bladder function or the stimulation for blood pressure control may be temporarily interrupted while applying stimulation for bowel/bladder function.
Stimulation for sexual function may be handled in the same or a similar way to stimulation for bowel/bladder function.
Prototype embodiments of systems as described herein have been tested on a number of subjects in a study that was approved by the clinical research ethics board of the University of Louisville, the University of California Los Angeles, and the University of British Columbia. Each of the subjects presented with motor, sensory, and autonomic completeness of injury. Each of the subjects provided written informed consent. All subjects of the study were:
An epidural spinal cord stimulation unit (RestoreADVANCED™, Medtronic, Minneapolis, MN, USA) in combination with a 16-electrode array paddle 301 (see
General Integrated Hemodynamic Assessment Approach
At least one month after implantation surgery, and following the development of a cardiovascular optimized stimulation paradigm (CV-scES); i.e., elucidating the optimum stimulation parameters that could modulate blood pressure) as shown at 201, we conducted a within person trial to investigate the immediate cardiovascular effects of CV-scES. The three participants were randomized to receive either stim-on or stim-off condition first and the two testing sessions were separated by no more than 24 hours.
Raw blood pressure traces 302 indicate that when the stimulator was activated there was an immediate reversal of orthostatic hypotension that was achieved in a controlled manner by gradually increasing voltage. Orthostatic hypotension prevailed again when the stimulator was turned off, demonstrating a capability to dynamically modulate blood pressure. Under steady state conditions, the stimulator was able to offset chronic hypotension by increasing and maintaining blood pressure approximately 20 mmHg above resting baseline, and increased low-frequency oscillations in systolic blood pressure indicating a return of medullary cardiovascular control.
Raw echocardiography imaging 303 in
Model-flow estimations 307 of mean arterial blood pressure, stroke volume, heart rate and systemic vascular resistance obtained from finger plethysmography along with raw transcranial Doppler images of the mid cerebral artery (MCA) and the posterior cerebral artery (PCA). Note the stepwise increase in all variables when the stimulator was activated (V), except heart rate which was offset due to the associated increase in stroke volume.
Raw changes in PCA velocity in response to cerebral activation (eyes open) 305 indicate the complete restoration of neurovascular coupling with stimulation (i.e., appropriate regulation of PCA velocity with cerebral activation). Lower-limb electromyography responses 305 to both low-frequency ‘motor-optimized’ and high-frequency ‘cardiovascular-optimized’ epidural stimulation reveal no concurrent motor activity during CV-optimized stimulation.
Unless the context clearly requires otherwise, throughout the description and the claims:
Words that indicate directions such as “vertical”, “transverse”, “horizontal”, “upward”, “downward”, “forward”, “backward”, “inward”, “outward”, “vertical”, “transverse”, “left”, “right”, “front”, “back”, “top”, “bottom”, “below”, “above”, “under”, and the like, used in this description and any accompanying claims (where present), depend on the specific orientation of the apparatus described and illustrated. The subject matter described herein may assume various alternative orientations. Accordingly, these directional terms are not strictly defined and should not be interpreted narrowly.
The following abbreviations have the following meanings:
The disclosure may also be provided in the form of a program product. The program product may comprise any non-transitory medium which carries a set of computer-readable instructions which, when executed by a data processor, cause the data processor to execute a method of the disclosure (e.g. a method as illustrated in
In some embodiments, the disclosure may be implemented in software. For greater clarity, “software” includes any instructions executed on a processor, and may include (but is not limited to) firmware, resident software, microcode, and the like. Both processing hardware and software may be centralized or distributed (or a combination thereof), in whole or in part, as known to those skilled in the art. For example, software and other modules may be accessible via local memory, via a network, via a browser or other application in a distributed computing context, or via other means suitable for the purposes described above.
Where a component (e.g. a software module, processor, assembly, device, circuit, etc.) is referred to above, unless otherwise indicated, reference to that component (including a reference to a “means”) should be interpreted as including as equivalents of that component any component which performs the function of the described component (i.e., that is functionally equivalent), including components which are not structurally equivalent to the disclosed structure which performs the function in the illustrated exemplary embodiments of the disclosure.
Specific examples of systems, methods and apparatus have been described herein for purposes of illustration. These are only examples. The technology provided herein can be applied to systems other than the example systems described above. Many alterations, modifications, additions, omissions, and permutations are possible within the practice of this disclosure. This disclosure includes variations on described embodiments that would be apparent to the skilled addressee, including variations obtained by: replacing features, elements and/or acts with equivalent features, elements and/or acts; mixing and matching of features, elements and/or acts from different embodiments; combining features, elements and/or acts from embodiments as described herein with features, elements and/or acts of other technology; and/or omitting combining features, elements and/or acts from described embodiments.
While processes or blocks are presented in a given order, alternative examples may perform routines having steps, or employ systems having blocks, in a different order, and some processes or blocks may be deleted, moved, added, subdivided, combined, and/or modified to provide alternative or subcombinations. Each of these processes or blocks may be implemented in a variety of different ways. Also, while processes or blocks are at times shown as being performed in series, these processes or blocks may instead be performed in parallel, or may be performed at different times.
Various features are described herein as being present in “some embodiments”. Such features are not mandatory and may not be present in all embodiments. Embodiments of the disclosure may include zero, any one or any combination of two or more of such features. This is limited only to the extent that certain ones of such features may be incompatible with other ones of such features in the sense that it would be impossible for a person of ordinary skill in the art to construct a practical embodiment that combines such incompatible features. Consequently, separate or combined statements in the description that “some embodiments” possess feature A and “some embodiments” possess feature B should be interpreted as an express indication that the disclosure also contemplate embodiments which combine features A and B (unless the description states otherwise or features A and B are fundamentally incompatible).
It is therefore intended that the following appended claims and claims hereafter introduced are interpreted to include all such modifications, permutations, additions, omissions, and sub-combinations as may reasonably be inferred. The scope of the claims should not be limited by the embodiments set forth in the examples, but should be given the broadest interpretation consistent with the description as a whole.
The present application is a continuation of U.S. Non-Provisional patent application Ser. No. 16/486,788, entitled “APPARATUS AND METHODS FOR MAINTAINING PHYSIOLOGICAL FUNCTIONS”, and filed on Aug. 16, 2019. U.S. Non-Provisional patent application Ser. No. 16/486,788 is a U.S. National Phase of International Application No. PCT/CA2018/050184 entitled “APPARATUS AND METHODS FOR MAINTAINING PHYSIOLOGICAL FUNCTIONS”, filed Feb. 16, 2018. International Application No. PCT/CA2018/050184 claims benefit of U.S. Provisional Application No. 62/460,224 filed Feb. 17, 2017 and entitled SERVO-CONTROLLED DEVICE TO MAINTAIN PHYSIOLOGICAL FUNCTIONING, U.S. Provisional Application No. 62/470,468 filed Mar. 13, 2017 and entitled SERVO CONTROLLED INTERFACE TO CONTROL ELECTRICAL STIMULATION FOR RESTORING PHYSIOLOGICAL FUNCTIONING, and U.S. Provisional Application No. 62/581,305 filed Nov. 3, 2017 and entitled SERVO CONTROLLED INTERFACE TO CONTROL ELECTRICAL STIMULATION FOR RESTORING PHYSIOLOGICAL FUNCTIONING. The entire contents of each of the above-listed applications are hereby incorporated by reference for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
2868343 | Sproul | Jan 1959 | A |
3543761 | Bradley | Dec 1970 | A |
3650277 | Sjostrand et al. | Mar 1972 | A |
3662758 | Glover | May 1972 | A |
3724467 | Avery et al. | Apr 1973 | A |
4044774 | Corbin et al. | Aug 1977 | A |
4102344 | Conway et al. | Jul 1978 | A |
4141365 | Fischell et al. | Feb 1979 | A |
4285347 | Hess | Aug 1981 | A |
4340063 | Maurer | Jul 1982 | A |
4379462 | Borkan et al. | Apr 1983 | A |
4398537 | Holmbo | Aug 1983 | A |
4414986 | Dickhudt et al. | Nov 1983 | A |
4538624 | Tarjan | Sep 1985 | A |
4549556 | Tarjan et al. | Oct 1985 | A |
4559948 | Liss et al. | Dec 1985 | A |
4569352 | Petrofsky et al. | Feb 1986 | A |
4573481 | Bullara | Mar 1986 | A |
4724842 | Charters | Feb 1988 | A |
4800898 | Hess et al. | Jan 1989 | A |
4934368 | Lynch | Jun 1990 | A |
4969452 | Petrofsky et al. | Nov 1990 | A |
5002053 | Garcia-Rill et al. | Mar 1991 | A |
5031618 | Mullett | Jul 1991 | A |
5066272 | Eaton et al. | Nov 1991 | A |
5081989 | Graupe et al. | Jan 1992 | A |
5121754 | Mullett | Jun 1992 | A |
5344439 | Otten | Sep 1994 | A |
5354320 | Schaldach et al. | Oct 1994 | A |
5366813 | Berlin | Nov 1994 | A |
5374285 | Vaiani et al. | Dec 1994 | A |
5417719 | Hull et al. | May 1995 | A |
5476441 | Durfee et al. | Dec 1995 | A |
5562718 | Palermo | Oct 1996 | A |
5643330 | Holsheimer et al. | Jul 1997 | A |
5733322 | Starkebaum | Mar 1998 | A |
5983141 | Sluijter et al. | Nov 1999 | A |
6058331 | King | May 2000 | A |
6066163 | John | May 2000 | A |
6104957 | Alo et al. | Aug 2000 | A |
6122548 | Starkebaum et al. | Sep 2000 | A |
6308103 | Gielen | Oct 2001 | B1 |
6319241 | King et al. | Nov 2001 | B1 |
6463327 | Lurie et al. | Oct 2002 | B1 |
6470213 | Alley | Oct 2002 | B1 |
6500110 | Davey et al. | Dec 2002 | B1 |
6503231 | Prausnitz et al. | Jan 2003 | B1 |
6505074 | Boveja et al. | Jan 2003 | B2 |
6516227 | Meadows et al. | Feb 2003 | B1 |
6551849 | Kenney | Apr 2003 | B1 |
6587724 | Mann | Jul 2003 | B2 |
6662053 | Borkan | Dec 2003 | B2 |
6666831 | Edgerton et al. | Dec 2003 | B1 |
6685729 | Gonzalez | Feb 2004 | B2 |
6748276 | Daignault, Jr. et al. | Jun 2004 | B1 |
6819956 | DiLorenzo | Nov 2004 | B2 |
6839594 | Cohen et al. | Jan 2005 | B2 |
6862479 | Whitehurst et al. | Mar 2005 | B1 |
6871099 | Whitehurst et al. | Mar 2005 | B1 |
6878112 | Linberg et al. | Apr 2005 | B2 |
6892098 | Ayal et al. | May 2005 | B2 |
6895280 | Meadows et al. | May 2005 | B2 |
6895283 | Erickson et al. | May 2005 | B2 |
6937891 | Leinders et al. | Aug 2005 | B2 |
6950706 | Rodriguez et al. | Sep 2005 | B2 |
6975907 | Zanakis et al. | Dec 2005 | B2 |
6988006 | King et al. | Jan 2006 | B2 |
6999820 | Jordan | Feb 2006 | B2 |
7020521 | Brewer et al. | Mar 2006 | B1 |
7024247 | Gliner et al. | Apr 2006 | B2 |
7035690 | Goetz | Apr 2006 | B2 |
7047084 | Erickson et al. | May 2006 | B2 |
7065408 | Herman et al. | Jun 2006 | B2 |
7096070 | Jenkins et al. | Aug 2006 | B1 |
7110820 | Tcheng et al. | Sep 2006 | B2 |
7127287 | Duncan et al. | Oct 2006 | B2 |
7127296 | Bradley | Oct 2006 | B2 |
7127297 | Law et al. | Oct 2006 | B2 |
7149773 | Haller et al. | Dec 2006 | B2 |
7153242 | Goffer | Dec 2006 | B2 |
7184837 | Goetz | Feb 2007 | B2 |
7200443 | Faul | Apr 2007 | B2 |
7209787 | DiLorenzo | Apr 2007 | B2 |
7228179 | Campen et al. | Jun 2007 | B2 |
7239920 | Thacker et al. | Jul 2007 | B1 |
7251529 | Greenwood-Van Meerveld | Jul 2007 | B2 |
7252090 | Goetz | Aug 2007 | B2 |
7313440 | Miesel | Dec 2007 | B2 |
7324853 | Ayal et al. | Jan 2008 | B2 |
7330760 | Heruth et al. | Feb 2008 | B2 |
7337005 | Kim et al. | Feb 2008 | B2 |
7337006 | Kim et al. | Feb 2008 | B2 |
7340298 | Barbut | Mar 2008 | B1 |
7381192 | Brodard et al. | Jun 2008 | B2 |
7415309 | McIntyre | Aug 2008 | B2 |
7463927 | Chaouat | Dec 2008 | B1 |
7463928 | Lee et al. | Dec 2008 | B2 |
7467016 | Colborn | Dec 2008 | B2 |
7493170 | Segel et al. | Feb 2009 | B1 |
7496404 | Meadows et al. | Feb 2009 | B2 |
7502652 | Gaunt et al. | Mar 2009 | B2 |
7536226 | Williams et al. | May 2009 | B2 |
7544185 | Bengtsson | Jun 2009 | B2 |
7584000 | Erickson | Sep 2009 | B2 |
7590454 | Garabedian et al. | Sep 2009 | B2 |
7603178 | North et al. | Oct 2009 | B2 |
7620502 | Selifonov et al. | Nov 2009 | B2 |
7628750 | Cohen et al. | Dec 2009 | B2 |
7647115 | Levin et al. | Jan 2010 | B2 |
7660636 | Castel et al. | Feb 2010 | B2 |
7697995 | Cross, Jr. et al. | Apr 2010 | B2 |
7725193 | Chu | May 2010 | B1 |
7729781 | Swoyer et al. | Jun 2010 | B2 |
7734340 | De Ridder | Jun 2010 | B2 |
7734351 | Testerman et al. | Jun 2010 | B2 |
7742037 | Sako et al. | Jun 2010 | B2 |
7769463 | Katsnelson | Aug 2010 | B2 |
7797057 | Harris | Sep 2010 | B2 |
7801601 | Maschino et al. | Sep 2010 | B2 |
7813803 | Heruth et al. | Oct 2010 | B2 |
7813809 | Strother et al. | Oct 2010 | B2 |
7856264 | Firlik et al. | Dec 2010 | B2 |
7877146 | Rezai et al. | Jan 2011 | B2 |
7890182 | Parramon et al. | Feb 2011 | B2 |
7949395 | Kuzma | May 2011 | B2 |
7949403 | Palermo et al. | May 2011 | B2 |
7987000 | Moffitt et al. | Jul 2011 | B2 |
7991465 | Bartic et al. | Aug 2011 | B2 |
8019427 | Moffitt | Sep 2011 | B2 |
8050773 | Zhu | Nov 2011 | B2 |
8108051 | Cross, Jr. et al. | Jan 2012 | B2 |
8108052 | Boling | Jan 2012 | B2 |
8131358 | Moffitt et al. | Mar 2012 | B2 |
8135473 | Miesel et al. | Mar 2012 | B2 |
8155750 | Jaax et al. | Apr 2012 | B2 |
8168481 | Hanaoka et al. | May 2012 | B2 |
8170660 | Dacey, Jr. et al. | May 2012 | B2 |
8190262 | Gerber et al. | May 2012 | B2 |
8195304 | Strother et al. | Jun 2012 | B2 |
8214048 | Whitehurst et al. | Jul 2012 | B1 |
8229565 | Kim et al. | Jul 2012 | B2 |
8239038 | Wolf, II | Aug 2012 | B2 |
8260436 | Gerber et al. | Sep 2012 | B2 |
8271099 | Swanson et al. | Sep 2012 | B1 |
8295936 | Wahlstrand et al. | Oct 2012 | B2 |
8311644 | Moffitt et al. | Nov 2012 | B2 |
8326569 | Lee et al. | Dec 2012 | B2 |
8332029 | Glukhovsky et al. | Dec 2012 | B2 |
8332047 | Libbus et al. | Dec 2012 | B2 |
8346366 | Arle et al. | Jan 2013 | B2 |
8352036 | DiMarco et al. | Jan 2013 | B2 |
8355791 | Moffitt | Jan 2013 | B2 |
8355797 | Caparso et al. | Jan 2013 | B2 |
8364273 | De Ridder | Jan 2013 | B2 |
8369961 | Christman et al. | Feb 2013 | B2 |
8374696 | Sanchez et al. | Feb 2013 | B2 |
8412345 | Moffitt | Apr 2013 | B2 |
8428728 | Sachs | Apr 2013 | B2 |
8442655 | Moffitt et al. | May 2013 | B2 |
8452406 | Arcot-Krishnamurthy et al. | May 2013 | B2 |
8543200 | Lane et al. | Sep 2013 | B2 |
8588884 | Hegde et al. | Nov 2013 | B2 |
8626300 | Demarais et al. | Jan 2014 | B2 |
8700145 | Kilgard et al. | Apr 2014 | B2 |
8712546 | Kim et al. | Apr 2014 | B2 |
8740825 | Ehrenreich et al. | Jun 2014 | B2 |
8750957 | Tang et al. | Jun 2014 | B2 |
8768481 | Lane | Jul 2014 | B2 |
8805542 | Tai et al. | Aug 2014 | B2 |
9072891 | Rao | Jul 2015 | B1 |
9079039 | Carlson et al. | Jul 2015 | B2 |
9101769 | Edgerton et al. | Aug 2015 | B2 |
9205259 | Kim et al. | Dec 2015 | B2 |
9205260 | Kim et al. | Dec 2015 | B2 |
9205261 | Kim et al. | Dec 2015 | B2 |
9248291 | Mashiach | Feb 2016 | B2 |
9272139 | Hamilton et al. | Mar 2016 | B2 |
9272143 | Libbus et al. | Mar 2016 | B2 |
9283391 | Ahmed | Mar 2016 | B2 |
9314630 | Levin et al. | Apr 2016 | B2 |
9393409 | Edgerton et al. | Jul 2016 | B2 |
9409023 | Burdick et al. | Aug 2016 | B2 |
9415218 | Edgerton et al. | Aug 2016 | B2 |
9421365 | Sumners et al. | Aug 2016 | B2 |
9597517 | Moffitt | Mar 2017 | B2 |
9610442 | Yoo et al. | Apr 2017 | B2 |
9802052 | Marnfeldt | Oct 2017 | B2 |
9895545 | Rao et al. | Feb 2018 | B2 |
9993642 | Gerasimenko et al. | Jun 2018 | B2 |
10092750 | Edgerton et al. | Oct 2018 | B2 |
10124166 | Edgerton et al. | Nov 2018 | B2 |
10137299 | Lu et al. | Nov 2018 | B2 |
10449371 | Serrano Carmona | Oct 2019 | B2 |
10751533 | Edgerton et al. | Aug 2020 | B2 |
10773074 | Liu et al. | Sep 2020 | B2 |
10806927 | Edgerton et al. | Oct 2020 | B2 |
10806935 | Rao et al. | Oct 2020 | B2 |
11097122 | Lu | Aug 2021 | B2 |
11123312 | Lu et al. | Sep 2021 | B2 |
20010016266 | Okazaki et al. | Aug 2001 | A1 |
20010032992 | Wendt | Oct 2001 | A1 |
20020042814 | Fukasawa et al. | Apr 2002 | A1 |
20020052539 | Haller et al. | May 2002 | A1 |
20020055779 | Andrews | May 2002 | A1 |
20020083240 | Hoese et al. | Jun 2002 | A1 |
20020111661 | Cross et al. | Aug 2002 | A1 |
20020115945 | Herman et al. | Aug 2002 | A1 |
20020188332 | Lurie et al. | Dec 2002 | A1 |
20020193843 | Hill et al. | Dec 2002 | A1 |
20030032992 | Thacker et al. | Feb 2003 | A1 |
20030078633 | Firlik et al. | Apr 2003 | A1 |
20030093021 | Goffer | May 2003 | A1 |
20030100933 | Ayal et al. | May 2003 | A1 |
20030114894 | Dar et al. | Jun 2003 | A1 |
20030158583 | Burnett et al. | Aug 2003 | A1 |
20030220679 | Han | Nov 2003 | A1 |
20030233137 | Paul, Jr. | Dec 2003 | A1 |
20040039425 | Greenwood-Van Meerveld | Feb 2004 | A1 |
20040044380 | Bruninga et al. | Mar 2004 | A1 |
20040111118 | Hill et al. | Jun 2004 | A1 |
20040111126 | Tanagho et al. | Jun 2004 | A1 |
20040122483 | Nathan et al. | Jun 2004 | A1 |
20040127954 | McDonald, III | Jul 2004 | A1 |
20040133248 | Frei et al. | Jul 2004 | A1 |
20040138518 | Rise et al. | Jul 2004 | A1 |
20040172027 | Speitling et al. | Sep 2004 | A1 |
20040172097 | Brodard et al. | Sep 2004 | A1 |
20040181263 | Balzer et al. | Sep 2004 | A1 |
20040267320 | Taylor et al. | Dec 2004 | A1 |
20050004622 | Cullen et al. | Jan 2005 | A1 |
20050061315 | Lee et al. | Mar 2005 | A1 |
20050070982 | Heruth et al. | Mar 2005 | A1 |
20050075669 | King | Apr 2005 | A1 |
20050075678 | Faul | Apr 2005 | A1 |
20050090756 | Wolf et al. | Apr 2005 | A1 |
20050101827 | Delisle | May 2005 | A1 |
20050102007 | Ayal et al. | May 2005 | A1 |
20050113882 | Cameron et al. | May 2005 | A1 |
20050119713 | Whitehurst et al. | Jun 2005 | A1 |
20050125045 | Brighton et al. | Jun 2005 | A1 |
20050209655 | Bradley et al. | Sep 2005 | A1 |
20050231186 | Saavedra Barrera et al. | Oct 2005 | A1 |
20050246004 | Cameron et al. | Nov 2005 | A1 |
20050277999 | Strother et al. | Dec 2005 | A1 |
20050278000 | Strother et al. | Dec 2005 | A1 |
20060003090 | Rodger et al. | Jan 2006 | A1 |
20060015153 | Gliner et al. | Jan 2006 | A1 |
20060018360 | Tai et al. | Jan 2006 | A1 |
20060041225 | Wallace et al. | Feb 2006 | A1 |
20060041295 | Osypka | Feb 2006 | A1 |
20060089696 | Olsen et al. | Apr 2006 | A1 |
20060100671 | Ridder | May 2006 | A1 |
20060111754 | Rezai et al. | May 2006 | A1 |
20060122678 | Olsen et al. | Jun 2006 | A1 |
20060142337 | Ikeura et al. | Jun 2006 | A1 |
20060142816 | Fruitman et al. | Jun 2006 | A1 |
20060142822 | Tulgar | Jun 2006 | A1 |
20060149333 | Tanagho et al. | Jul 2006 | A1 |
20060149337 | John | Jul 2006 | A1 |
20060189839 | Laniado et al. | Aug 2006 | A1 |
20060195153 | DiUbaldi et al. | Aug 2006 | A1 |
20060239482 | Hatoum | Oct 2006 | A1 |
20060241356 | Flaherty | Oct 2006 | A1 |
20060282127 | Zealear | Dec 2006 | A1 |
20070004567 | Shetty et al. | Jan 2007 | A1 |
20070016097 | Farquhar et al. | Jan 2007 | A1 |
20070016266 | Paul, Jr. | Jan 2007 | A1 |
20070016329 | Herr et al. | Jan 2007 | A1 |
20070021513 | Agee et al. | Jan 2007 | A1 |
20070027395 | Gerber | Feb 2007 | A1 |
20070047852 | Sharp et al. | Mar 2007 | A1 |
20070049814 | Muccio | Mar 2007 | A1 |
20070055337 | Tanrisever | Mar 2007 | A1 |
20070060954 | Cameron et al. | Mar 2007 | A1 |
20070060980 | Strother et al. | Mar 2007 | A1 |
20070067003 | Sanchez et al. | Mar 2007 | A1 |
20070073357 | Rooney et al. | Mar 2007 | A1 |
20070083240 | Peterson et al. | Apr 2007 | A1 |
20070100389 | Jaax et al. | May 2007 | A1 |
20070121702 | LaGuardia et al. | May 2007 | A1 |
20070121709 | Ittogi | May 2007 | A1 |
20070142874 | John | Jun 2007 | A1 |
20070150023 | Ignagni et al. | Jun 2007 | A1 |
20070156172 | Alvarado | Jul 2007 | A1 |
20070156179 | S. E. | Jul 2007 | A1 |
20070156200 | Kornet et al. | Jul 2007 | A1 |
20070168008 | Olsen | Jul 2007 | A1 |
20070179534 | Firlik et al. | Aug 2007 | A1 |
20070179579 | Feler et al. | Aug 2007 | A1 |
20070191709 | Swanson | Aug 2007 | A1 |
20070208381 | Hill et al. | Sep 2007 | A1 |
20070233204 | Lima et al. | Oct 2007 | A1 |
20070255372 | Metzler et al. | Nov 2007 | A1 |
20070265621 | Matthis et al. | Nov 2007 | A1 |
20070265679 | Bradley et al. | Nov 2007 | A1 |
20070265691 | Swanson | Nov 2007 | A1 |
20070276449 | Gunter et al. | Nov 2007 | A1 |
20070276450 | Meadows et al. | Nov 2007 | A1 |
20070293910 | Strother et al. | Dec 2007 | A1 |
20080002227 | Tsujimoto | Jan 2008 | A1 |
20080004674 | King et al. | Jan 2008 | A1 |
20080009927 | Vilims | Jan 2008 | A1 |
20080021513 | Thacker et al. | Jan 2008 | A1 |
20080027346 | Litt et al. | Jan 2008 | A1 |
20080046049 | Skubitz et al. | Feb 2008 | A1 |
20080051851 | Lin | Feb 2008 | A1 |
20080071325 | Bradley | Mar 2008 | A1 |
20080077192 | Harry et al. | Mar 2008 | A1 |
20080103579 | Gerber | May 2008 | A1 |
20080105185 | Kuhlman | May 2008 | A1 |
20080140152 | Imran et al. | Jun 2008 | A1 |
20080140162 | Goetz et al. | Jun 2008 | A1 |
20080140169 | Imran | Jun 2008 | A1 |
20080147143 | Popovic et al. | Jun 2008 | A1 |
20080154329 | Pyles et al. | Jun 2008 | A1 |
20080183224 | Barolat | Jul 2008 | A1 |
20080200749 | Zheng et al. | Aug 2008 | A1 |
20080202940 | Jiang et al. | Aug 2008 | A1 |
20080207985 | Farone | Aug 2008 | A1 |
20080208287 | Palermo et al. | Aug 2008 | A1 |
20080215113 | Pawlowicz | Sep 2008 | A1 |
20080221653 | Agrawal et al. | Sep 2008 | A1 |
20080224226 | Suzuki et al. | Sep 2008 | A1 |
20080228241 | Sachs | Sep 2008 | A1 |
20080228250 | Mironer | Sep 2008 | A1 |
20080234121 | Kim et al. | Sep 2008 | A1 |
20080234791 | Arle et al. | Sep 2008 | A1 |
20080279896 | Heinen et al. | Nov 2008 | A1 |
20080294211 | Moffitt | Nov 2008 | A1 |
20080294226 | Moffitt et al. | Nov 2008 | A1 |
20090012436 | Lanfermann et al. | Jan 2009 | A1 |
20090024997 | Kobayashi | Jan 2009 | A1 |
20090093854 | Leung et al. | Apr 2009 | A1 |
20090112281 | Miyazawa et al. | Apr 2009 | A1 |
20090118365 | Benson, III et al. | May 2009 | A1 |
20090131995 | Sloan et al. | May 2009 | A1 |
20090157141 | Chiao et al. | Jun 2009 | A1 |
20090198305 | Naroditsky et al. | Aug 2009 | A1 |
20090204173 | Fang et al. | Aug 2009 | A1 |
20090229166 | Sawrie | Sep 2009 | A1 |
20090270960 | Zhao et al. | Oct 2009 | A1 |
20090281529 | Carriazo | Nov 2009 | A1 |
20090281599 | Thacker et al. | Nov 2009 | A1 |
20090293270 | Brindley et al. | Dec 2009 | A1 |
20090299166 | Nishida et al. | Dec 2009 | A1 |
20090299167 | Seymour | Dec 2009 | A1 |
20090306491 | Haggers | Dec 2009 | A1 |
20100004715 | Fahey | Jan 2010 | A1 |
20100010646 | Drew et al. | Jan 2010 | A1 |
20100023103 | Elborno | Jan 2010 | A1 |
20100029040 | Nomoto | Feb 2010 | A1 |
20100042193 | Slavin | Feb 2010 | A1 |
20100070007 | Parker et al. | Mar 2010 | A1 |
20100114205 | Donofrio et al. | May 2010 | A1 |
20100114239 | McDonald, III | May 2010 | A1 |
20100125313 | Lee et al. | May 2010 | A1 |
20100137238 | Gan et al. | Jun 2010 | A1 |
20100137938 | Kishawi et al. | Jun 2010 | A1 |
20100145428 | Cameron et al. | Jun 2010 | A1 |
20100152811 | Flaherty | Jun 2010 | A1 |
20100166546 | Mahan et al. | Jul 2010 | A1 |
20100168820 | Maniak et al. | Jul 2010 | A1 |
20100185253 | Dimarco et al. | Jul 2010 | A1 |
20100198298 | Glukhovsky et al. | Aug 2010 | A1 |
20100217355 | Tass et al. | Aug 2010 | A1 |
20100228310 | Shuros et al. | Sep 2010 | A1 |
20100241121 | Logan et al. | Sep 2010 | A1 |
20100241191 | Testerman et al. | Sep 2010 | A1 |
20100268299 | Farone | Oct 2010 | A1 |
20100274312 | Alataris et al. | Oct 2010 | A1 |
20100280570 | Sturm et al. | Nov 2010 | A1 |
20100305660 | Hegi et al. | Dec 2010 | A1 |
20100312304 | York et al. | Dec 2010 | A1 |
20100318168 | Bighetti | Dec 2010 | A1 |
20100331925 | Peterson | Dec 2010 | A1 |
20110006793 | Peschke et al. | Jan 2011 | A1 |
20110009919 | Carbunaru et al. | Jan 2011 | A1 |
20110016081 | Basak et al. | Jan 2011 | A1 |
20110029040 | Walker et al. | Feb 2011 | A1 |
20110029044 | Hyde et al. | Feb 2011 | A1 |
20110034277 | Brandes | Feb 2011 | A1 |
20110034977 | Janik et al. | Feb 2011 | A1 |
20110040349 | Graupe | Feb 2011 | A1 |
20110054567 | Lane et al. | Mar 2011 | A1 |
20110054568 | Lane et al. | Mar 2011 | A1 |
20110054570 | Lane | Mar 2011 | A1 |
20110054579 | Kumar et al. | Mar 2011 | A1 |
20110077660 | Janik et al. | Mar 2011 | A1 |
20110082515 | Libbus et al. | Apr 2011 | A1 |
20110084489 | Kaplan | Apr 2011 | A1 |
20110093043 | Torgerson et al. | Apr 2011 | A1 |
20110112601 | Meadows et al. | May 2011 | A1 |
20110125203 | Simon et al. | May 2011 | A1 |
20110130804 | Lin et al. | Jun 2011 | A1 |
20110152967 | Simon et al. | Jun 2011 | A1 |
20110160810 | Griffith | Jun 2011 | A1 |
20110166546 | Jaax et al. | Jul 2011 | A1 |
20110184482 | Eberman et al. | Jul 2011 | A1 |
20110184488 | De Ridder | Jul 2011 | A1 |
20110184489 | Nicolelis et al. | Jul 2011 | A1 |
20110202107 | Sunagawa et al. | Aug 2011 | A1 |
20110208265 | Erickson et al. | Aug 2011 | A1 |
20110213266 | Williams et al. | Sep 2011 | A1 |
20110218590 | Degiorgio et al. | Sep 2011 | A1 |
20110218594 | Doron et al. | Sep 2011 | A1 |
20110224153 | Levitt et al. | Sep 2011 | A1 |
20110224665 | Crosby et al. | Sep 2011 | A1 |
20110224752 | Rolston et al. | Sep 2011 | A1 |
20110224753 | Palermo et al. | Sep 2011 | A1 |
20110224757 | Zdeblick et al. | Sep 2011 | A1 |
20110230101 | Tang et al. | Sep 2011 | A1 |
20110230701 | Simon et al. | Sep 2011 | A1 |
20110230702 | Honour | Sep 2011 | A1 |
20110231326 | Marino | Sep 2011 | A1 |
20110237221 | Prakash et al. | Sep 2011 | A1 |
20110237921 | Prakash et al. | Sep 2011 | A1 |
20110245734 | Wagner et al. | Oct 2011 | A1 |
20110276107 | Simon et al. | Nov 2011 | A1 |
20110288609 | Tehrani et al. | Nov 2011 | A1 |
20110295100 | Hegde et al. | Dec 2011 | A1 |
20120006793 | Swanson | Jan 2012 | A1 |
20120011950 | Kracke | Jan 2012 | A1 |
20120013041 | Cao et al. | Jan 2012 | A1 |
20120013126 | Molloy | Jan 2012 | A1 |
20120016448 | Lee | Jan 2012 | A1 |
20120029528 | MacDonald et al. | Feb 2012 | A1 |
20120035684 | Thompson et al. | Feb 2012 | A1 |
20120041518 | Kim et al. | Feb 2012 | A1 |
20120052432 | Matsuura | Mar 2012 | A1 |
20120059432 | Emborg et al. | Mar 2012 | A1 |
20120071250 | O'Neil et al. | Mar 2012 | A1 |
20120071950 | Archer | Mar 2012 | A1 |
20120083709 | Parker et al. | Apr 2012 | A1 |
20120101326 | Simon et al. | Apr 2012 | A1 |
20120109251 | Lebedev et al. | May 2012 | A1 |
20120109295 | Fan | May 2012 | A1 |
20120116476 | Kothandaraman | May 2012 | A1 |
20120123223 | Freeman et al. | May 2012 | A1 |
20120123293 | Shah et al. | May 2012 | A1 |
20120126392 | Kälvesten et al. | May 2012 | A1 |
20120136408 | Grill et al. | May 2012 | A1 |
20120165899 | Gliner | Jun 2012 | A1 |
20120172222 | Artigas Puerto | Jul 2012 | A1 |
20120172246 | Nguyen et al. | Jul 2012 | A1 |
20120172946 | Alataris et al. | Jul 2012 | A1 |
20120179222 | Jaax et al. | Jul 2012 | A1 |
20120185020 | Simon et al. | Jul 2012 | A1 |
20120197338 | Su et al. | Aug 2012 | A1 |
20120203055 | Pletnev | Aug 2012 | A1 |
20120203131 | DiLorenzo | Aug 2012 | A1 |
20120221073 | Southwell et al. | Aug 2012 | A1 |
20120232615 | Barolat et al. | Sep 2012 | A1 |
20120252380 | Kawakita | Oct 2012 | A1 |
20120252874 | Feinstein et al. | Oct 2012 | A1 |
20120259380 | Pyles | Oct 2012 | A1 |
20120271372 | Osorio | Oct 2012 | A1 |
20120277824 | Li | Nov 2012 | A1 |
20120277834 | Mercanzini et al. | Nov 2012 | A1 |
20120283697 | Kim et al. | Nov 2012 | A1 |
20120302821 | Burnett | Nov 2012 | A1 |
20120310305 | Kaula et al. | Dec 2012 | A1 |
20120310315 | Savage et al. | Dec 2012 | A1 |
20120330321 | Johnson et al. | Dec 2012 | A1 |
20120330391 | Bradley et al. | Dec 2012 | A1 |
20130012853 | Brown | Jan 2013 | A1 |
20130013041 | Glukhovsky et al. | Jan 2013 | A1 |
20130026640 | Ito et al. | Jan 2013 | A1 |
20130030312 | Keel et al. | Jan 2013 | A1 |
20130030319 | Hettrick et al. | Jan 2013 | A1 |
20130030501 | Feler et al. | Jan 2013 | A1 |
20130035745 | Ahmed et al. | Feb 2013 | A1 |
20130053734 | Barriskill et al. | Feb 2013 | A1 |
20130053922 | Ahmed et al. | Feb 2013 | A1 |
20130066392 | Simon et al. | Mar 2013 | A1 |
20130085317 | Feinstein | Apr 2013 | A1 |
20130085361 | Mercanzini et al. | Apr 2013 | A1 |
20130096640 | Possover | Apr 2013 | A1 |
20130096661 | Greenberg et al. | Apr 2013 | A1 |
20130096662 | Swanson | Apr 2013 | A1 |
20130110196 | Alataris et al. | May 2013 | A1 |
20130116751 | Moffitt et al. | May 2013 | A1 |
20130123568 | Hamilton et al. | May 2013 | A1 |
20130123659 | Bartol et al. | May 2013 | A1 |
20130138167 | Bradley et al. | May 2013 | A1 |
20130165991 | Kim et al. | Jun 2013 | A1 |
20130197408 | Goldfarb et al. | Aug 2013 | A1 |
20130204324 | Thacker et al. | Aug 2013 | A1 |
20130211477 | Cullen et al. | Aug 2013 | A1 |
20130237948 | Donders et al. | Sep 2013 | A1 |
20130253222 | Nakao | Sep 2013 | A1 |
20130253229 | Sawant et al. | Sep 2013 | A1 |
20130253299 | Weber et al. | Sep 2013 | A1 |
20130253611 | Lee et al. | Sep 2013 | A1 |
20130268016 | Xi et al. | Oct 2013 | A1 |
20130268021 | Moffitt | Oct 2013 | A1 |
20130281890 | Mishelevich | Oct 2013 | A1 |
20130289446 | Stone et al. | Oct 2013 | A1 |
20130289650 | Karlsson et al. | Oct 2013 | A1 |
20130289664 | Johanek | Oct 2013 | A1 |
20130289667 | Wacnik et al. | Oct 2013 | A1 |
20130296965 | Mokelke et al. | Nov 2013 | A1 |
20130303873 | Vörös et al. | Nov 2013 | A1 |
20130304159 | Simon et al. | Nov 2013 | A1 |
20130310211 | Wilton et al. | Nov 2013 | A1 |
20130310911 | Tai et al. | Nov 2013 | A1 |
20140005753 | Carbunaru | Jan 2014 | A1 |
20140031893 | Walker et al. | Jan 2014 | A1 |
20140046407 | Ben-Ezra et al. | Feb 2014 | A1 |
20140058292 | Alford et al. | Feb 2014 | A1 |
20140058490 | DiMarco | Feb 2014 | A1 |
20140066950 | MacDonald et al. | Mar 2014 | A1 |
20140067007 | Drees et al. | Mar 2014 | A1 |
20140067354 | Kaula et al. | Mar 2014 | A1 |
20140074190 | Griffith | Mar 2014 | A1 |
20140081011 | Vaught | Mar 2014 | A1 |
20140081071 | Simon et al. | Mar 2014 | A1 |
20140088674 | Bradley | Mar 2014 | A1 |
20140100633 | Mann et al. | Apr 2014 | A1 |
20140107397 | Simon et al. | Apr 2014 | A1 |
20140107398 | Simon et al. | Apr 2014 | A1 |
20140114374 | Rooney et al. | Apr 2014 | A1 |
20140163640 | Edgerton et al. | Jun 2014 | A1 |
20140172045 | Yip et al. | Jun 2014 | A1 |
20140180361 | Burdick et al. | Jun 2014 | A1 |
20140213842 | Simon et al. | Jul 2014 | A1 |
20140228905 | Bolea | Aug 2014 | A1 |
20140236257 | Parker et al. | Aug 2014 | A1 |
20140243923 | Doan et al. | Aug 2014 | A1 |
20140277271 | Chan et al. | Sep 2014 | A1 |
20140296752 | Edgerton et al. | Oct 2014 | A1 |
20140303901 | Sadeh | Oct 2014 | A1 |
20140316484 | Edgerton et al. | Oct 2014 | A1 |
20140316503 | Tai et al. | Oct 2014 | A1 |
20140324118 | Simon et al. | Oct 2014 | A1 |
20140330067 | Jordan | Nov 2014 | A1 |
20140330335 | Errico et al. | Nov 2014 | A1 |
20140336722 | Rocon De Lima et al. | Nov 2014 | A1 |
20140357936 | Simon et al. | Dec 2014 | A1 |
20150005840 | Pal et al. | Jan 2015 | A1 |
20150065559 | Feinstein et al. | Mar 2015 | A1 |
20150066111 | Blum et al. | Mar 2015 | A1 |
20150165226 | Simon et al. | Jun 2015 | A1 |
20150182784 | Barriskill et al. | Jul 2015 | A1 |
20150190634 | Rezai et al. | Jul 2015 | A1 |
20150196231 | Ziaie et al. | Jul 2015 | A1 |
20150217120 | Nandra et al. | Aug 2015 | A1 |
20150231396 | Burdick et al. | Aug 2015 | A1 |
20150265830 | Simon et al. | Sep 2015 | A1 |
20150328462 | Griffith | Nov 2015 | A1 |
20160001096 | Mishelevich | Jan 2016 | A1 |
20160030737 | Gerasimenko et al. | Feb 2016 | A1 |
20160030748 | Edgerton et al. | Feb 2016 | A1 |
20160030750 | Bokil et al. | Feb 2016 | A1 |
20160045727 | Rezai et al. | Feb 2016 | A1 |
20160045731 | Simon et al. | Feb 2016 | A1 |
20160074663 | De Ridder | Mar 2016 | A1 |
20160121109 | Edgerton et al. | May 2016 | A1 |
20160121114 | Simon et al. | May 2016 | A1 |
20160121116 | Simon et al. | May 2016 | A1 |
20160121121 | Mashiach | May 2016 | A1 |
20160143588 | Hoitink et al. | May 2016 | A1 |
20160157389 | Hwang | Jun 2016 | A1 |
20160220813 | Edgerton et al. | Aug 2016 | A1 |
20160235977 | Lu et al. | Aug 2016 | A1 |
20160175586 | Edgerton et al. | Sep 2016 | A1 |
20160271413 | Vallejo et al. | Sep 2016 | A1 |
20160279418 | Courtine et al. | Sep 2016 | A1 |
20160279429 | Hershey et al. | Sep 2016 | A1 |
20160310739 | Burdick et al. | Oct 2016 | A1 |
20170007320 | Levin et al. | Jan 2017 | A1 |
20170056661 | Lin et al. | Mar 2017 | A1 |
20170128729 | Netoff et al. | May 2017 | A1 |
20170007831 | Edgerton et al. | Jun 2017 | A1 |
20170157389 | Tai et al. | Jun 2017 | A1 |
20170157396 | Dixon et al. | Jun 2017 | A1 |
20170161454 | Grill et al. | Jun 2017 | A1 |
20170165497 | Lu | Jun 2017 | A1 |
20170173326 | Bloch et al. | Jun 2017 | A1 |
20170246450 | Liu et al. | Aug 2017 | A1 |
20170246452 | Liu et al. | Aug 2017 | A1 |
20170266455 | Steinke | Sep 2017 | A1 |
20170274209 | Edgerton et al. | Sep 2017 | A1 |
20170296837 | Jin | Oct 2017 | A1 |
20170354819 | Bloch et al. | Dec 2017 | A1 |
20170361093 | Yoo et al. | Dec 2017 | A1 |
20180056078 | Kashyap et al. | Mar 2018 | A1 |
20180085583 | Zhang et al. | Mar 2018 | A1 |
20180104479 | Grill et al. | Apr 2018 | A1 |
20180110992 | Parramon et al. | Apr 2018 | A1 |
20180125416 | Schwarz et al. | May 2018 | A1 |
20180178008 | Bouton et al. | Jun 2018 | A1 |
20180185642 | Lu | Jul 2018 | A1 |
20180185648 | Nandra et al. | Jul 2018 | A1 |
20180193655 | Zhang et al. | Jul 2018 | A1 |
20180229037 | Edgerton et al. | Aug 2018 | A1 |
20180229038 | Burdick et al. | Aug 2018 | A1 |
20180236240 | Harkema et al. | Aug 2018 | A1 |
20180256906 | Pivonka et al. | Sep 2018 | A1 |
20180280693 | Edgerton et al. | Oct 2018 | A1 |
20180353755 | Edgerton et al. | Dec 2018 | A1 |
20180361146 | Gerasimenko et al. | Dec 2018 | A1 |
20190022371 | Chang et al. | Jan 2019 | A1 |
20190033622 | Olgun et al. | Jan 2019 | A1 |
20190160294 | Peterson et al. | May 2019 | A1 |
20190167987 | Lu et al. | Jun 2019 | A1 |
20190192864 | Koop et al. | Jun 2019 | A1 |
20190247650 | Tran | Aug 2019 | A1 |
20190269917 | Courtine et al. | Sep 2019 | A1 |
20190381313 | Lu | Dec 2019 | A1 |
20190381328 | Wechter et al. | Dec 2019 | A1 |
20200155865 | Lu | May 2020 | A1 |
20200228901 | Baek | Jul 2020 | A1 |
20210069052 | Burke | Mar 2021 | A1 |
20210187278 | Lu | Jun 2021 | A1 |
20210236837 | Lu | Aug 2021 | A1 |
20210378991 | Lu et al. | Dec 2021 | A1 |
Number | Date | Country |
---|---|---|
2012204526 | Sep 2016 | AU |
2856202 | May 2013 | CA |
2864473 | May 2013 | CA |
2823592 | Nov 2021 | CA |
101227940 | Jul 2008 | CN |
103263727 | Aug 2013 | CN |
104307098 | Jan 2015 | CN |
0630987 | Dec 1994 | EP |
2130326 | Dec 2009 | EP |
2141851 | Jan 2010 | EP |
2160127 | Mar 2010 | EP |
2178319 | Apr 2010 | EP |
2192897 | Jun 2010 | EP |
2226114 | Sep 2010 | EP |
2258496 | Dec 2010 | EP |
2361631 | Aug 2011 | EP |
2368401 | Sep 2011 | EP |
2387467 | Nov 2011 | EP |
2396995 | Dec 2011 | EP |
2397788 | Dec 2011 | EP |
2445990 | May 2012 | EP |
2471518 | Jul 2012 | EP |
2475283 | Jul 2012 | EP |
2486897 | Aug 2012 | EP |
2626051 | Aug 2013 | EP |
2628502 | Aug 2013 | EP |
2661307 | Nov 2013 | EP |
2688642 | Jan 2014 | EP |
2810689 | Dec 2014 | EP |
2810690 | Dec 2014 | EP |
2868343 | May 2015 | EP |
2966422 | Jan 2016 | EP |
2968940 | Jan 2016 | EP |
3184145 | Jun 2017 | EP |
3323468 | May 2018 | EP |
3328481 | Jun 2018 | EP |
3527258 | Aug 2019 | EP |
H0326620 | Feb 1991 | JP |
3184145 | Jul 2001 | JP |
2002200178 | Jul 2002 | JP |
2004065529 | Mar 2004 | JP |
2007526798 | Sep 2007 | JP |
2008067917 | Mar 2008 | JP |
2008543429 | Dec 2008 | JP |
2014514043 | Jun 2014 | JP |
2016506255 | Mar 2016 | JP |
6132856 | Apr 2017 | JP |
2017104685 | Jun 2017 | JP |
2017525509 | Sep 2017 | JP |
2018524113 | Aug 2018 | JP |
2130326 | May 1999 | RU |
2141851 | Nov 1999 | RU |
2160127 | Dec 2000 | RU |
2178319 | Jan 2002 | RU |
2192897 | Nov 2002 | RU |
2193441 | Nov 2002 | RU |
2226114 | Mar 2004 | RU |
2258496 | Aug 2005 | RU |
2361631 | Jul 2009 | RU |
2368401 | Sep 2009 | RU |
2387467 | Apr 2010 | RU |
2396995 | Aug 2010 | RU |
2397788 | Aug 2010 | RU |
2445990 | Mar 2012 | RU |
2471518 | Jan 2013 | RU |
2475283 | Feb 2013 | RU |
2661307 | Jul 2018 | RU |
97047357 | Dec 1997 | WO |
02034331 | May 2002 | WO |
02092165 | Nov 2002 | WO |
03005887 | Jan 2003 | WO |
03026735 | Apr 2003 | WO |
03092795 | Nov 2003 | WO |
2004087116 | Oct 2004 | WO |
2005002663 | Jan 2005 | WO |
2005051306 | Jun 2005 | WO |
2005065768 | Jul 2005 | WO |
2005087307 | Sep 2005 | WO |
2006138069 | Dec 2006 | WO |
2007007058 | Jan 2007 | WO |
2007012114 | Feb 2007 | WO |
2007047852 | Apr 2007 | WO |
2007081764 | Jul 2007 | WO |
2007107831 | Sep 2007 | WO |
2008070807 | Jun 2008 | WO |
2008075294 | Jun 2008 | WO |
2008109862 | Sep 2008 | WO |
2008121891 | Oct 2008 | WO |
2009042217 | Apr 2009 | WO |
2009111142 | Sep 2009 | WO |
2010021977 | Feb 2010 | WO |
2010055421 | May 2010 | WO |
2010114998 | Oct 2010 | WO |
2010124128 | Oct 2010 | WO |
2011005607 | Jan 2011 | WO |
2011136875 | Nov 2011 | WO |
2012050200 | Apr 2012 | WO |
2012075195 | Jun 2012 | WO |
2012080964 | Jun 2012 | WO |
2012094346 | Jul 2012 | WO |
2012100260 | Jul 2012 | WO |
2012129574 | Sep 2012 | WO |
2013071307 | May 2013 | WO |
2013071309 | May 2013 | WO |
2013152124 | Oct 2013 | WO |
2013179230 | Dec 2013 | WO |
2013188965 | Dec 2013 | WO |
2014005075 | Jan 2014 | WO |
2014031142 | Feb 2014 | WO |
2014089299 | Jun 2014 | WO |
2014144785 | Sep 2014 | WO |
2014149895 | Sep 2014 | WO |
2014205356 | Dec 2014 | WO |
2014209877 | Dec 2014 | WO |
2015000800 | Jan 2015 | WO |
2015048563 | Apr 2015 | WO |
2015063127 | May 2015 | WO |
2015106286 | Jul 2015 | WO |
2016029159 | Feb 2016 | WO |
2016033369 | Mar 2016 | WO |
2016033372 | Mar 2016 | WO |
2016064761 | Apr 2016 | WO |
2016110804 | Jul 2016 | WO |
2016112398 | Jul 2016 | WO |
2016172239 | Oct 2016 | WO |
2017011410 | Jan 2017 | WO |
2017024276 | Feb 2017 | WO |
2017035512 | Mar 2017 | WO |
2017044904 | Mar 2017 | WO |
2017058913 | Apr 2017 | WO |
2017062508 | Apr 2017 | WO |
2017117450 | Jul 2017 | WO |
2017146659 | Aug 2017 | WO |
2018039296 | Mar 2018 | WO |
2018106843 | Jun 2018 | WO |
2018160531 | Aug 2018 | WO |
2018217791 | Nov 2018 | WO |
2019211314 | Nov 2019 | WO |
2020041502 | Feb 2020 | WO |
2020041633 | Feb 2020 | WO |
2020236946 | Nov 2020 | WO |
Entry |
---|
Anderson, K., “Targeting Recovery: Priorities of the Spinal Cord-Injured Population,” Journal of Neurotrauma, vol. 21, No. 10, Oct. 2004, 13 pages. |
Krassioukov, A. et al., “A Systematic Review of the Management of Autonomic Dysreflexia Following Spinal Cord Injury,” Archives of Physical Medicine and Rehabilitation, vol. 90, No. 4, Apr. 2009, 27 pages. |
Krassioukov, A. et al., “A Systematic Review of the Management of Orthostatic Hypotension Following Spinal Cord Injury,” Archives of Physical Medicine and Rehabilitation, vol. 90, No. 5, May 2009, 22 pages. |
Wan, D. et al., “Life-threatening outcomes associated with autonomic dysreflexia: A clinical review,” Journal of Spinal Cord Medicine, vol. 37, No. 1, Jan. 2014, 9 pages. |
Phillips, A. et al., “Perturbed and spontaneous regional cerebral blood flow responses to changes in blood pressure after high-level spinal cord injury: the effect of midodrine,” Journal of Applied Physiology, vol. 116, No. 6, Mar. 15, 2014, Available Online Jan. 16, 2014, 20 pages. |
Phillips, A. et al., “Regional neurovascular coupling and cognitive performance in those with low blood pressure secondary to high-level spinal cord injury: improved by alpha-1 agonist midodrine hydrochloride,” Journal of Cerebral Blood Flow & Metabolism, vol. 34, No. 5, May 2014, 8 pages. |
Phillips, A. et al., “Contemporary Cardiovascular Concerns after Spinal Cord Injury: Mechanisms, Maladaptations, and Management,” Journal of Neurotrama, vol. 32, No. 24, Dec. 15, 2015, 17 pages. |
Robbins, H., “Some Aspects of the Sequential Design of Experiments,” Bulletin of the American Mathematical Society, vol. 58, Sep. 1, 1952, 9 pages. |
Minoux, M., “Accelerated greedy algorithms for maximizing submodular set functions,” Optimization Techniques, Proceedings of the LNCIS, vol. 7, 1978, 10 pages. |
Gittins, J. C., “Bandit Processes and Dynamic Allocation Indices,” Journal of the Royal Statistical Society B, vol. 41, No. 2, Jan. 1979, 17 pages. |
Harrison, P. et al., “Individual Excitatory Post-Synaptic Potentials Due to Muscle Spindle la Afferents in Cat Triceps Surae Motoneurones,” The Journal of Physiology, vol. 312, No. 1, Mar. 1981, 16 pages. |
Lovely, R. et al., “Effects of Training on the Recovery of Full-Weight-Bearing Stepping in the Adult Spinal Cat,” Experimental Neurology, vol. 92, No. 2, May 1986, 15 pages. |
Barbeau, H. et al., “Recovery of locomotion after chronic spinalization in the adult cat,” Brain Research, vol. 412, No. 1, May 26, 1987, 12 pages. |
Colgate, E. et al., “An Analysis of Contact Instability in Terms of Passive Physical Equivalents,” Proceedings of the 1989 IEEE International Conference on Robotics and Automation, Scottsdale, Arizona, May 14, 1989, 6 pages. |
Wernig, A. et al., “Laufband locomotion with body weight support improved walking in persons with severe spinal cord injuries,” Paraplegia, vol. 30, No. 4, Apr. 1992, 10 pages. |
Pratt, J. et al., “Series elastic actuators for high fidelity force control,” Industrial Robot: An International Journal, vol. 29, No. 3, Available as Early as Jan. 1, 2002, 13 pages. |
Winter, D. A. et al., “An integrated EMG/biomechanical model of upper body balance and posture during human gait,” Progress in Brain Research, vol. 97, Ch. 32, Available as Early as Jan. 1, 1993, 9 pages. |
Pratt, G. et al., “Stiffness Isn't Everything,” Proceedings of the Fourth International Symposium on Experimental Robotics, Jun. 30, 1995, Stanford, California, 6 pages. |
Basso, D. et al., “MASCIS Evaluation of Open Field Locomotor Scores: Effects of Experience and Teamwork on Reliability,” Journal of Neurotrauma, vol. 13, No. 7, Jul. 1996, 17 pages. |
Harkema, S. et al., “Human Lumbosacral Spinal Cord Interprets Loading During Stepping,” Journal of Neurophysiology, vol. 77, No. 2, Feb. 1, 1997, 15 pages. |
Brosamle, C. et al., “Cells of Origin, Course, and Termination Patterns of the Ventral, Uncrossed Component of the Mature Rat Corticospinal Tract,” The Journal of Comparative Neurology, vol. 386, No. 2, Sep. 22, 1997, 11 pages. |
Jones, D. R. et al., “Efficient Global Optimization of Expensive Black-Box Functions,” Journal of Global Optimization, vol. 13, 1998, 38 pages. |
Dimitrijevic, M. M. et al., “Evidence for a Spinal Central Pattern Generator in Humans,” Annals New York Academy Sciences, vol. 860, 1998, 17 pages. |
Kakulas, B., “A Review of the Neuropathology of Human Spinal Cord Injury with Emphasis on Special Features,” Proceedings of the Donald Munro Memorial Lecture at the American Paraplegia Society 44th Annual Conference, Sep. 9, 1998, Las Vegas, Nevada, 6 pages. |
Hashtrudi-Zaad, K. et al., “On the Use of Local Force Feedback for Transparent Teleoperation,” Proceedings of the 1999 IEEE International Conference on Robotics and Automation, May 10, 1999, Detroit, Michigan, 7 pages. |
Kirkwood, P., “Neuronal Control of Locomotion: From Mollusk to Man—G.N. Orlovsky, T.G. Deliagina and S. Grillner, Oxford University Press,” Clinical Neurophysiology, vol. 111, No. 8, Published Online Jul. 17, 2000, Aug. 1, 2000, 2 pages. |
Murg, M. et al., “Epidural electric stimulation of posterior structures of the human lumbar spinal cord: 1. Muscle twitches—a functional method to define the site of stimulation.” Spinal Cord, vol. 38, 2000, 9 pages. |
Auer, P. et al., “Finite-time Analysis of the Multiarmed Bandit Problem,” Machine Learning, vol. 47, No. 2, 2002, 22 pages. |
Auer, P. “Using Confidence Bounds for Exploitation-Exploration Trade-offs,” Journal of Machine Learning Research, vol. 3, 2002, 26 pages. |
Dimitrijevic, M. et al., “Clinical Elements for the Neuromuscular Stimulation and Functional Electrical Stimulation protocols in the Practice of Neurorehabilitation,” Artificial Organs, vol. 26, No. 3, 2002, 4 pages. |
Gerasimenko, Y. et al., “Control of Locomotor Activity in Humans and Animals in the Absence of Supraspinal Influences,” Neuroscience and Behavioral Physiology, vol. 32, No. 4, 2002, 7 pages. |
Herman, R. et al., “Spinal cord stimulation facilitates functional walking in a chronic, incomplete spinal cord injured,” Spinal Cord, vol. 40, No. 2, 2002, 4 pages. |
Yakovenko, S. et al., “Spatiotemporal Activation of Lumbosacral Motoneurons in the Locomotor Step Cycle,” Journal of Neurophysiology, vol. 87, No. 3, Mar. 2002, 12 pages. |
Ivanenko, Y. P. et al., “Temporal Components of the Motor Patterns Expressed by the Human Spinal Cord Reflect Foot Kinematics,” Journal of Neurophysiology, vol. 90, No. 5, Nov. 2003, Published Online Jul. 9, 2003, 11 pages. |
Steward, O. et al., “False Resurrections: Distinguishing Regenerated from Spared Axons in the Injured Central Nervous System,” The Journal of Comparative Neurology, vol. 459, No. 1, Apr. 21, 2003, 8 pages. |
Minassian, K. et al., “Stepping-like movements in humans with complete spinal cord injury induced by epidural stimulation of the lumbar cord: electromyographic study of compound muscle action potentials”, Spinal Cord, vol. 42, 2004, 16 pages. |
Pearson, K., “Generating the walking gait: role of sensory feedback,” Progress in Brain Research, vol. 143, Chapter 12, Published Online Nov. 28, 2003, 2004, 7 pages. |
Rasmussen, C., “Gaussian Processes in Machine Learning”, L.N.A.I., vol. 3176, 2003, 9 pages. |
Carhart, M. et al., “Epidural Spinal-Cord Stimulation Facilitates Recovery of Functional Walking Following Incomplete Spinal-Cord Injury,” IEEE Transactions on Neural Systems and Rehabilitation Engineering, vol. 12, No. 1, Mar. 15, 2004, 11 pages. |
Bareyre, F. et al., “The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats,” Nature Neuroscience, vol. 7, No. 3, Published Online Feb. 15, 2004, Mar. 2004, 9 pages. |
Dimitrijevic, M. et al., “Electrophysiological characteristics of H-reflexes elicited by percutaneous stimulation of the cauda equina,” Abstract No. 4927, Proceedings of the 34th Annual Meeting of the Society for Neuroscience, San Diego, California, 2004, 1 page. |
Jilge, B. et al., “Initiating extension of the lower limbs in subjects with complete spinal cord injury by epidural lumbar cord stimulation,” Experimental Brain Research, vol. 154, 2004, 19 pages. |
Ganley, K. et al., “Epidural Spinal Cord Stimulation Improves Locomotor Performance in Low ASIA C, Wheelchair-Dependent, Spinal Cord-Injured Individuals: Insights from Metabolic Response,” Topics in Spinal Cord Injury Rehabilitation, vol. 11, No. 2, 2005, 14 pages. |
Krause, A. et al., “Near-optimal Nonmyopic Value of Information in Graphical Models,” Proceedings of the Twenty-First Conference on Uncertainty in Artificial Intelligence (UAI'05), 2005, Edinburgh, Scotland, 8 pages. |
Minassian, K. et al., “Peripheral and central afferent input to the lumbar cord,” Biocybemetics and Biomedical Engineering, vol. 25, No. 3, 2005, 19 pages. |
Liu, J. et al., “Stimulation of the Parapyramidal Region of the Neonatal Rat Brain Stem Produces Locomotor-Like Activity Involving Spinal 5-HT7 and 5-HT2A Receptors,” Journal of Neurophysiology, vol. 94, No. 2, Published Online May 4, 2005, Aug. 1, 2005, 13 pages. |
Timozyk, W. et al., “Hindlimb loading determines stepping quantity and quality following spinal cord transection,” Brain Research, vol. 1050, No. 1-2, Published Online Jun. 24, 2005, Jul. 19, 2005, 10 pages. |
Wernig, A., “Ineffectiveness▪ of Automated Locomotor Training,” Archives of Physical Medicine and Rehabilitation, vol. 86, No. 12, Dec. 2005, 2 pages. |
Nessler, J. et al., “A Robotic Device for Studying Rodent Locomotion After Spinal Cord Injury,” IEEE Transactions on Neural Systems and Rehabilitation Engineering, vol. 13, No. 4, Dec. 12, 2005, 10 pages. |
Rasmussen, C. et al., “Gaussian Processes for Machine Learning,” The MIT Press, Cambridge, Massachusetts, 2006, 266 pages. |
Pudo, D. et al., “Estimating Intensity Fluctuations in High Repetition Rate Pulse Trains Generated Using the Temporal Talbot Effect,” IEEE Photonics Technology Letters, vol. 18, No. 5, Mar. 1, 2006, 3 pages. |
Reinkensmeyer, D. et al., “Tools for understanding and optimizing robotic gait training,” Journal of Rehabilitation Research & Development, vol. 43, No. 5, Aug. 2006, 14 pages. |
Frey, M. et al., “A Novel Mechatronic Body Weight Support System,” IEEE Transactions on Neural Systems and Rehabilitation Engineering, vol. 14, No. 3, Sep. 18, 2006, 11 pages. |
Kocsis, L. et al. “Bandit Based Monte-Carlo Planning,” Proceedings of the European Conference on Machine Learning, Springer, Berlin, Heidelberg, Sep. 2006, 12 pages. |
Fleshman, J. et al., “Electronic Architecture of Type-Identified a-Motoneurons in the Cat Spinal Cord,” Journal of Neurophysiology, vol. 60, No. 1, Jul. 1, 1988, 26 pages. |
Jones, K. et al., “Computer Simulation of the Responses of Human Motoneurons to Composite 1A EPSPS: Effects of Background Firing Rate,” The Journal of Physiology, vol. 77, No. 1, 1997, 16 pages. |
Hines, M. et al., “The Neuron Simulation Environment,” Neural Computation, vol. 9, No. 6, Aug. 15, 1997, 26 pages. |
Prochazka, A. et al., “Ensemble firing of muscle afferents recorded during normal locomotion in cats,” The Journal of Physiology, vol. 507, No. 1, Feb. 15, 1998, 12 pages. |
Prochazka, A. et al., “Models of ensemble filing of muscle spindle afferents recorded during normal locomotion in cats,” The Journal of Physiology, vol. 507, No. 1, Feb. 15, 1998, 15 pages. |
Rattay, F. et al., “Epidural electrical stimulation of posterior structures of the human lumbosacral cord: 2. Quantitative analysis by computer modeling,” Spinal Cord, vol. 38, 2000, 17 pages. |
Mcintyre, C. et al., “Modeling the Excitability of Mammalian Nerve Fibers: Influence of Afterpotentials on the Recovery Cycle,” Journal of Neurophysiology, vol. 87, No. 2, Feb. 2002, 12 pages. |
Minassian, K. et al., “Human lumbar cord circuitries can be activated by extrinsic tonic input to generate locomotor-like activity,” Human Movement Science, vol. 26, No. 2, 2007, 21 pages. |
Rodger, D. et al., “High Density Flexible Parylene-Based Multielectrode Arrays for Retinal and Spinal Cord Stimulation,” Proceedings of the 14th International Conference on Solid-State Sensors, Actuators and Microsystems, 2007, pp. 4 pages. |
Stienen, A. et al., “Analysis of reflex modulation with a biologically realistic neural network,” Journal of Computer Neuroscience, vol. 23, No. 3, Dec. 2007, Available Online May 15, 2007, 16 pages. |
Johnson, W. et al., “Application of a Rat Hindlimb Model: A Prediction of Force Spaces Reachable Through Stimulation of Nerve Fascicles,” IEEE Transactions on Bio-Medical Engineering, vol. 58, No. 12, Dec. 2011, Available Online Jan. 17, 2011, 22 pages. |
Van Den Brand, R. et al., “Restoring Voluntary Control of Locomotion after Paralyzing Spinal Cord Injury,” Science Magazine, vol. 336, No. 6085, Jun. 1, 2012, 5 pages. |
Hennig, P. et al., “Entropy search for information-efficient global optimization,” Journal of Machine Learning Research (JMLR), vol. 13, Jun. 2012, 29 pages. |
Gilja, V. et al., “A high-performance neural prosthesis enabled by control algorithm design,” Nature Neuroscience, vol. 15, No. 12, Dec. 2012, Published Online Nov. 18, 2012, 56 pages. |
Minassian, K. et al., “Neuromodulation of lower limb motor control in restorative neurology,” Clinical Neurology and Neurosurgery, vol. 114, 2012, 9 pages.pp. 489-497. |
Ryzhov, I. et al., “The knowledge gradient algorithm for a general class of online learning problems,” Operations Research, vol. 60, No. 1, 2012, 47 pages. |
Azimi, J. et al., “Hybrid Batch Bayesian Optimization,” Proceedings of the 29th International Conference on Machine Learning, 2012, Edinburgh, Scotland, 12 pages. |
Azimi, J. et al., “Batch Active Learning via Coordinated Matching,” Proceedings of the 29th International Conference on Machine Learning, 2012, Edinburgh, Scotland, 8 pages. |
Lozano, A. et al., “Probing and Regulating Dysfunctional Circuits Using Deep Brain Stimulation,” Neuron, vol. 77, No. 3, Feb. 6, 2013, 19 pages. |
Minassian et al., “Mechanisms of rhythm generation of the human lumbar spinal cord in repose to tonic stimulation without and with step-related sensory feedback,” Biomedizinische Technik, vol. 58, (Suppl. 1), 2013, 3 pages. |
Capogrosso, M. et al., “A Computational Model for Epidural Electrical Stimulation of Spinal Sensorimotor Circuits”, Journal of Neuroscience, vol. 33, No. 49, Dec. 4, 2013, 15 pages. |
Sayenko, D. et al., “Neuromodulation of evoked muscle potentials induced by epidural spinal-cord stimulation in paralyzed individuals,” Journal of Neurophysiology, vol. 111, No. 5, 2014, Published Online Dec. 11, 2013, 12 pages. |
Hofstoetter, U. et al., “Effects of transcutaneous spinal cord stimulation on voluntary locomotor activity in an incomplete spinal cord injured individual,” Biomed Tech, vol. 58 (Suppl. 1), 2013, 3 pages. |
Nandra, M. et al., “Microelectrode Implants for Spindal Cord Stimulation in Rats,” Doctor of Philosophy Thesis, California Institute of Technology, 2014, 104 pages. |
Angeli, C. et al., “Altering spinal cord excitability enables voluntary movements after chronic complete paralysis in humans,” Brain, vol. 137, No. 5, May 2014, Available Online Apr. 8, 2014, 16 pages. |
Zhang, T. et al., “Mechanisms and models of spinal cord stimulation for the treatment of neuropathic pain,” Brain Research, vol. 1569, Jun. 20, 2014, Published Online May 4, 2014, 14 pages. |
Wenger, N. et al. “Closed-loop neuromodulation of spinal sensorimotor circuits controls refined locomotion after complete spinal cord injury,” Science Translational Medicine, Sep. 24, 2014, vol. 6, No. 255, 10 pages. |
Wenger, N. et al., “Supplementary Materials for Closed-loop neuromodulation of spinal sensorimotor circuits controls refined locomotion after complete spinal cord injury,” Science Translational Medicine, vol. 6, No. 255, Sep. 24, 2014, 14 pages. |
Takeoka, A. et al., “Muscle Spindle Feedback Directs Locomotor Recovery and Circuit Reorganization after Spinal Cord Injury,” Cell, vol. 159, No. 7, Dec. 18, 2014, 27 pages. |
Hofstoetter, U. et al., “Modification of spasticity by transcutaneous spinal cord stimulation in individuals with incomplete spinal cord injury,” The Journal of Spinal Cord Medicine, vol. 37, No. 2, 2014, 10 pages. |
Minev, I. et al., “Electronic dura mater for long-term multimodal neural interfaces,” Science Magazine, vol. 347, No. 6218, Jan. 9, 2015, 64 pages. |
Gerasimenko, Y. et al., “Noninvasive Reactivation of Motor Descending Control after Paralysis,” Journal of Neurotrauma, vol. 32, 2015, 13 pages. |
Danner, S. et al., “Human spinal locomotor control is based on flexibly organized burst generators,” Brain, vol. 138, No. 3, Mar. 2015, Available Online Jan. 12, 2015, 12 pages. |
Rejc, E. et al., “Effects of Lumbosacral Spinal Cord Epidural Stimulation for Standing after Chronic Complete Paralysis in Humans,” PLoS One, vol. 10, No. 7, Jul. 24, 2015, 20 pages. |
Shamir, R. et al., “Machine Learning Approach to Optimizing Combined Stimulation and Medication Therapies for Parkinson's Disease,” Brain Stimulation, vol. 8, No. 6, Nov. 2015, Published Online Jun. 15, 2015, 22 pages. |
Jarosiewicz, B. et al., “Virtual typing by people with tetraplegia using a self-calibrating intracortical brain-computer interface,” Science Translational Medicine, vol. 7, No. 313, Nov. 11, 2015, 11 pages. |
Jarosiewicz, B. et al., “Supplementary Materials for Virtual typing by people with tetraplegia using a self-calibrating intracortical brain-computer interface,” Science Translational Medicine, vol. 7, No. 313, Nov. 11, 2015, 26 pages. |
Moraud, E. et al., “Mechanisms Underlying the Neuromodulation of Spinal Circuits for Correcting Gait and Balance Deficits after Spinal Cord Injury,” Neuron, vol. 89, No. 4, Feb. 17, 2016, Published Online Feb. 4, 2016, 15 pages. |
Danner, S. M. et al., “Body Position Influences Which neural structures are recruited by lumbar transcutaneous spinal cord stimulation”, PLoS One, vol. 11, No. 1, 2016, 13 pages. |
Burke, R., “Group la Synaptic Input to Fast and Slow Twitch Motor Units of Cat Triceps Surae,” The Journal of Physiology, vol. 196, vol. 3, Jun. 1, 1968, 26 pages. |
Cai, L. et al., “Implications of Assist-As-Needed Robotic Step Training after a Complete Spinal Cord Injury on Intrinsic Strategies of Motor Learning,” The Journal of Neuroscience, vol. 26, No. 41, Oct. 11, 2006, 5 pages. |
Courtine, G. et al., “Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans?,” Nature Medicine, vol. 13, No. 5, May 2007, 13 pages. |
Drew, T. et al., “Cortical mechanisms involved in visuomotor coordination during precision walking,” Brain Research Reviews, vol. 57, No. 1, Jan. 2007, Published Online Aug. 22, 2007, 13 pages. |
Edgerton, V. et al., “Training Locomotor Networks,” Brain Research Reviews, vol. 57, Jan. 2008, Published Online Sep. 16, 2007, 25 pages. |
Kwakkel, G. et al., “Effects of Robot-assisted therapy on upper limb recovery after stroke: A Systematic Review,” Neurorehabilitation and Neural Repair, vol. 22, No. 2, Mar. 2008, Published Online Sep. 17, 2007, 17 pages. |
Lizotte, D. et al., “Automatic gait optimization with Gaussian process regression,” Proceedings of the 20th international joint conference on Artifical intelligence (IJCAI), Jan. 6, 2007, Hyderabad, India, 6 pages. |
Courtine, G. et al., “Recovery of supraspinal control of stepping via indirect propriospinal relay connections after spinal cord injury,” Nature Medicine, vol. 14, No. 1, Jan. 6, 2008, 6 pages. |
Cowley, K. et al., “Propriospinal neurons are sufficient for bulbospinal transmission of the locomotor command signal in the neonatal rat spinal cord,” The Journal of Physiology, vol. 586, No. 6, Mar. 15, 2008, Published Online Jan. 31, 2008, 13 pages. |
Krause, A. et al. “Near-Optimal Sensor Placements in Gaussian Processes: Theory, Efficient Algorithms and Empirical Studies,” Journal of Machine Learning Research (JMLR), vol. 9, Feb. 2008, 8 pages. |
Lavrov, I. et al., “Epidural Stimulation Induced Modulation of Spinal Locomotor Networks in Adult Spinal Rats,” Journal of Neuroscience, vol. 28, No. 23, Jun. 4, 2008, 8 pages. |
Vallery, H. et al., “Compliant Actuation of Rehabilitation Robots,” IEEE Robotics & Automation Magazine, vol. 15, No. 3, Sep. 12, 2008, 10 pages. |
Abernethy, J. et al., “Competing in the Dark: An Efficient Algorithm for Bandit Linear Optimization,” Conference on Learning Theory, 2008, 13 pages. |
Bubeck, S. et al., “Online Optimization in X-Armed Bandits,” Advances in Neural Information Processing Systems (NIPS), 2008, 8 pages. |
Ward, A. R., “Electrical Stimulation Using Kilohertz-Frequency Alternating Current,” Physical Therapy, vol. 89, 2009, Published online Dec. 18, 2008, 10 pages. |
Dani, V. et al., “Stochastic Linear Optimization Under Bandit Feedback,” Proceedings of the 21st Annual Conference on Learning Theory (COLT), 2008, Helsinki, Finland, 15 pages. |
Edgerton, V. et al., “Robotic Training and Spinal Cord Plasticity,” Brain Research Bulletin, vol. 78, No. 1, Jan. 15, 2009, Published Online Nov. 14, 2008, 19 pages. |
Hofstoetter, U. et al., “Modification of Reflex Responses to Lumbar Posterior Root Stimulation by Motor Tasks in Healthy Subjects,” Artificial Organs, vol. 32, No. 8, 2008, 5 pages. |
Kleinberg, R. et al., “Multi-armed bandits in metric spaces,” Proceedings of the STOC, Computer and Automation Research Institute of the Hungarian Academy of Sciences, Budapest, Hungary, 2008, 26 pages. |
Brochu, E. et al., “A Tutorial on Bayesian Optimization of Expensive Cost Functions, with Application to Active User Modeling and Hierarchical Reinforcement Learning,” TR-2009-23, UBC, 2009, 49 pages. |
Bubeck, S. et al., “Pure Exploration in Finitely-Armed and Continuous-Armed Bandits problems,” ALT, 2009, 35 pages. |
Fuentes, R. et al., “Spinal Cord Stimulation Restores Locomotion in Animal Models of Parkinson's Disease,” Science, vol. 323, No. 5921, Mar. 20, 2009, 14 pages. |
Hofstoetter, U. et al., “Model of spinal cord reflex circuits in humans: Stimulation frequency-dependence of segmental activities and their interactions,” Proceedings of the Second Congress International Society of Intraoperative Neurophysiology (ISIN), Dubrovnik, Croatia, 2009, 149 pages. |
Courtine, G. et al., “Transformation of nonfunctional spinal circuits into functional states after the loss of brain input,” Nature Neuroscience, vol. 12, No. 10, Oct. 2009, Published Online Sep. 20, 2009, 12 pages. |
Minassian, K. et al., “Posterior root-muscle reflex,” Proceedings of the Second Congress International Society of Intraoperative Neurophysiology (ISIN), Dubrovnik, Croatia, 2009, 6 pages. |
Musienko, P. et al., “Combinatory Electrical and Pharmacological Neuroprosthetic Interfaces to Regain Motor Function After Spinal Cord Injury,” IEEE Transactions on Biomedical Engineering, vol. 56, No. 11, Nov. 2009, Published Online Jul. 24, 2009, 5 pages. |
Alto, L. et al., “Chemotropic Guidance Facilitates Axonal Regeneration and Synapse Formation after Spinal Cord Injury,” Nature Neuroscience, vol. 12, No. 9, Sep. 2009, Published Online Aug. 2, 2009, 22 pages. |
Azimi, J. et al., “Batch Bayesian Optimization via Simulation Matching,” Proceedings of the Advances in Neural Information Processing Systems (NIPS), 2010, Vancouver, British Columbia, Canada, 9 pages. |
Hagglund, M. et al., “Activation of groups of excitatory neurons in the mammalian spinal cord or hindbrain evokes locomotion,” Nature Neuroscience, vol. 13, No. 2, Feb. 2010, Published Online Jan. 17, 2010, 8 pages. |
Wessels, M. et al., “Body Weight-Supported Gait Training for Restoration of Walking in People with an Incomplete Spinal Cord Injury: A Systematic Review,” Journal of Rehabilitation Medicine, vol. 42, No. 6, Jun. 2010, 7 pages. |
Duschau-Wicke, A. et al., “Patient-cooperative control increases active participation of individuals with SCI during robot-aided gait training,” Journal of NeuroEngineering and Rehabilitation, vol. 7, No. 43, Sep. 10, 2010, 13 pages. |
Ladenbauer, J. et al., “Stimulation of the human lumbar spinal cord with implanted and surface electrodes: a computer simulation study,” IEEE Transactions on Neural Systems and Rehabilitation Engineering, vol. 18, No. 6, 2010, 9 pages. |
Minassian, K. et al., “Transcutaneous stimulation of the human lumbar spinal cord: Facilitating locomotor output in spinal cord injury,” Proceedings of the Society for Neuroscience, Conference Proceedings, Neuroscience 2010, San Diego, CA, Abstract Viewer/ Itinerary Planner No. 286. 19, Abstract & Poster Attached, 2010, 1 page. |
Rasmussen, C. E. et al., “Gaussian Processes for Machine Learning (GPML) Toolbox,” The Journal of Machine Learning Research, vol. 11, 2010, 9 pages. |
Widmer, C. et al., “Inferring latent task structure for multitask learning by multiple kernel learning,” BMC Bioinformatics, vol. 11, Suppl 8:S5, 2010, 8 pages. |
Rosenzweig, E. et al., “Extensive Spontaneous Plasticity of Corticospinal Projections After Primate Spinal Cord Injury,” Nature Neuroscience, vol. 13, No. 12, Dec. 2010, Published Online Nov. 14, 2010, 19 pages. |
Srinivas, N. et al., “Gaussian process optimization in the bandit setting: No. regret and experimental design,” Proceedings of the 27th International Conference on Machine Learning, 2010, Haifa, Israel, 17 pages. |
Tenne, Y. et al., “Computational Intelligence in Expensive Optimization Problems,” Adaptation, Learning, and Optimization, vol. 2, Springer, Berlin Heidelberg, 2010, 32 pages. |
Zorner, B. et al., “Profiling locomotor recovery: comprehensive quantification of impairments after CNS damage in rodents,” Nature Methods, vol. 7, No. 9, Sep. 2010, Published Online Aug. 15, 2010, 11 pages. |
Ada, L. et al., “Mechanically assisted walking with body weight support results in more independent walking than assisted overground walking in non-ambulatory patients early after stroke: a systematic review,” Journal of Physiotherapy, vol. 56, No. 3, Sep. 2010, 9 pages. |
Hidler, J. et al., “ZeroG: Overground gait and balance training system,” Journal of Rehabilitation Research & Development, vol. 48, No. 4, Available as Early as Jan. 1, 2011, 12 pages. |
Harkema, S. et al., “Effect of Epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study,” Lancet, vol. 377, No. 9781, Jun. 4, 2011, Available Online May 19, 2011, 17 pages. |
Krause, A. et al. “Contextual Gaussian Process Bandit Optimization”, In Advances in Neural Information Processing Systems (NIPS), 2011, 9 pages. |
Musselman, K. et al., “Spinal Cord Injury Functional Ambulation Profile: A New Measure of Walking Ability,” Neurorehabilitation and Neural Repair, vol. 25, No. 3, Published Online Feb. 25, 2011, (Mar. 2011), 9 pages. |
Wirz, M. et al., “Effectiveness of automated locomotor training in patients with acute incomplete spinal cord injury: A randomized controlled multicenter trial,” BMC Neurology, vol. 11, No. 60, May 27, 2011, 9 pages. |
Musienko, P. et al., “Controlling specific locomotor behaviors through multidimensional monoaminergic modulation of spinal circuitries,” The Journal of Neuroscience, vol. 31, No. 25, Jun. 22, 2011, 32 pages. |
Musienko, P. et al. “Multi-system neurorehabilitative strategies to restore motor functions following severe spinal cord injury,” Experimental Neurology, vol. 235, No. 1, Published Online Sep. 7, 2011, (May 2012), 10 pages. |
Nandra, M. S. et al., “A parylene-based microelectrode array implant for spinal cord stimulation in rats,” Proceedings of the IEEE Engineering in Medicine and Biology Society, 2011, Boston, Massachusetts, 13 pages. |
Sun, F. et al., “Sustained axon regeneration induced by co-deletion of PTEN and SOCS3,” Nature, vol. 480, No. 7377, Dec. 15, 2011, Published Online Nov. 6, 2011, 12 pages. |
Number | Date | Country | |
---|---|---|---|
20220111208 A1 | Apr 2022 | US |
Number | Date | Country | |
---|---|---|---|
62581305 | Nov 2017 | US | |
62470468 | Mar 2017 | US | |
62460224 | Feb 2017 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16486788 | US | |
Child | 17644765 | US |